<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Dev Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Dev Biol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31380366</article-id>
<article-id pub-id-type="pmc">6656924</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2019.00119</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Modulation of Nerve Cell Differentiation: Role of Polyphenols and of Contactin Family Components</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Picocci</surname>
<given-names>Sabrina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/635459/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bizzoca</surname>
<given-names>Antonella</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/667442/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corsi</surname>
<given-names>Patrizia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/766984/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magrone</surname>
<given-names>Thea</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/202375/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jirillo</surname>
<given-names>Emilio</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/184540/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gennarini</surname>
<given-names>Gianfranco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/398121/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratories of Developmental Neurobiology, Department of Basic Medical Sciences, Neurosciences and Sensory Organs, Medical School, University of Bari Aldo Moro</institution>, <addr-line>Bari</addr-line>, <country>Italy</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratories of Immunology, Department of Basic Medical Sciences, Neurosciences and Sensory Organs, Medical School, University of Bari Aldo Moro</institution>, <addr-line>Bari</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tadahide Furuno, Aichi Gakuin University, Japan</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Asami Oguro-Ando, University of Exeter, United Kingdom; David Lutz, Ruhr-Universität Bochum, Germany</p>
</fn>
<corresp id="c001">*Correspondence: Gianfranco Gennarini, <email>gianfranco.gennarini@uniba.it</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>7</volume>
<elocation-id>119</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Picocci, Bizzoca, Corsi, Magrone, Jirillo and Gennarini.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Picocci, Bizzoca, Corsi, Magrone, Jirillo and Gennarini</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>In this study the mechanisms are explored, which modulate expression and function of cell surface adhesive glycoproteins of the Immunoglobulin Supergene Family (IgSF), and in particular of its Contactin subset, during neuronal precursor developmental events. In this context, a specific topic concerns the significance of the expression profile of such molecules and their ability to modulate signaling pathways activated through nutraceuticals, in particular polyphenols, administration. Both <italic>in vitro</italic> and <italic>in vivo</italic> approaches are chosen. As for the former, by using as a model the human SH-SY5Y neuroblastoma line, the effects of grape seed polyphenols are evaluated on proliferation and commitment/differentiation events along the neuronal lineage. In SH-SY5Y cell cultures, polyphenols were found to counteract precursor proliferation while promoting their differentiation, as deduced by studying their developmental parameters through the expression of cell cycle and neuronal commitment/differentiation markers as well as by measuring neurite growth. In such cultures, Cyclin E expression and BrdU incorporation were downregulated, indicating reduced precursor proliferation while increased neuronal differentiation was inferred from upregulation of cell cycle exit (p27<sup>–Kip</sup>) and neuronal commitment (NeuN) markers as well as by measuring neurite length through morphometric analysis. The polyphenol effects on developmental parameters were also explored <italic>in vivo</italic>, in cerebellar cortex, by using as a model the TAG/F3 transgenic line, which undergoes delayed neural development as a consequence of Contactin1 adhesive glycoprotein upregulation and premature expression under control of the Contactin2 gene (<italic>Cntn-2</italic>) promoter. In this transgenic line, a Notch pathway activation is known to occur and polyphenol treatment was found to counteract such an effect, demonstrated through downregulation of the Hes-1 transcription factor. Polyphenols also downregulated the expression of adhesive glycoproteins of the Contactin family themselves, demonstrated for both Contactin1 and Contactin2, indicating the involvement of changes in the expression of the underlying genes in the observed phenotype. These data support the hypothesis that the complex control exerted by polyphenols on neural development involves modulation of expression and function of the genes encoding cell adhesion molecules of the Contactin family and of the associated signaling pathways, indicating potential mechanisms whereby such compounds may control neurogenesis.</p>
</abstract>
<kwd-group>
<kwd>contactins</kwd>
<kwd>gene regulation</kwd>
<kwd>neural development</kwd>
<kwd>Notch pathway</kwd>
<kwd>polyphenols</kwd>
</kwd-group>
<counts>
<fig-count count="12"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="124"></ref-count>
<page-count count="19"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Adhesive glycoproteins modulate different events of neurogenesis, including precursor proliferation, commitment, and differentiation (<xref ref-type="bibr" rid="B72">Missaire and Hindges, 2015</xref>). In the context of this regulatory role a special concern is on those pathways, which mediate the developmental control of such events (<xref ref-type="bibr" rid="B83">Pollerberg et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Frei and Stoeckli, 2014</xref>; <xref ref-type="bibr" rid="B108">Stoeckli, 2018</xref>). Such pathways may imply the function of cell surface adhesive glycoproteins belonging to different gene families as for instance the Cadherins and the Semaphorins (<xref ref-type="bibr" rid="B42">Hirano and Takeichi, 2012</xref>; <xref ref-type="bibr" rid="B50">Jongbloets and Pasterkamp, 2014</xref>) and, in this study, we focus on components of the large Immunoglobulin Supergene Family (IgSF; <xref ref-type="bibr" rid="B23">Dityatev et al., 2008</xref>; <xref ref-type="bibr" rid="B109">Stoeckli et al., 2013</xref>; <xref ref-type="bibr" rid="B30">Frei and Stoeckli, 2017</xref>) and, mostly, on its Contactin subset with a special focus on Contactin1 (<xref ref-type="bibr" rid="B107">Stoeckli, 2010</xref>, <xref ref-type="bibr" rid="B108">2018</xref>; <xref ref-type="bibr" rid="B118">Xenaki et al., 2011</xref>; <xref ref-type="bibr" rid="B123">Zuko et al., 2011</xref>, <xref ref-type="bibr" rid="B124">2013</xref>; <xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>, <xref ref-type="bibr" rid="B87">2015</xref>; <xref ref-type="bibr" rid="B73">Mohebiany et al., 2014</xref>; <xref ref-type="bibr" rid="B36">Gennarini and Furley, 2017</xref>; <xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>).</p>
<p>On a mechanistic ground, the Contactin1 function implies its ability to interact with and to modulate developmental control pathways, among which a pivotal role is played by the one associated with Notch receptors (<xref ref-type="bibr" rid="B57">Louvi and Artavanis-Tsakonas, 2006</xref>; <xref ref-type="bibr" rid="B121">Zhang et al., 2018</xref>). Indeed, besides by the Delta and Serrate canonical ligands (<xref ref-type="bibr" rid="B117">Wang, 2011</xref>), Notch receptors activation may also result upon their interactions with non-canonical ligands and a relevant role in this respect has been demonstrated for components of the Contactin family (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>, <xref ref-type="bibr" rid="B45">2006</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>). Contactins are glycosylphosphatidylinositol (GPI)-anchored cell surface glycoproteins, which include six components, labeled from Contactin1 to Contactin6. These molecules share a similar overall organization as they are built by structurally related domains, which may belong to either the Immunoglobulin type C2 and/or the Fibronectin type III subtypes, whose variable association generates the IgC2/FNIII IgSF subset (<xref ref-type="bibr" rid="B90">Ranscht, 1988</xref>; <xref ref-type="bibr" rid="B34">Gennarini et al., 1989</xref>, <xref ref-type="bibr" rid="B35">1991</xref>; <xref ref-type="bibr" rid="B101">Shimoda and Watanabe, 2009</xref>). While bearing comparable overall organization and functional roles at the cellular level, a specific developmental significance for such molecules relies upon the differential activation profiles of the underlying genes, which, in turn, may sustain their complex interactions via either homo- or heterophylic mechanisms (<xref ref-type="bibr" rid="B73">Mohebiany et al., 2014</xref>). In these molecules, the association of immunoglobulin type C2 with Fibronectin type III domains is justified by their similar organization (<xref ref-type="bibr" rid="B17">Cota et al., 2001</xref>), which, in turn, is relevant for those mechanisms, which are involved in developing nervous tissue patterning. Indeed, IgC2/FNIII proteins expression profiles and molecular interactions are both ontogenetically regulated, which may be relevant for their ability to activate developmental control pathways (<xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>).</p>
<p>Close relationships in terms of structural organization, expression profiles and functional roles have been originally demonstrated in the case of the first two identified members of the IgC2/FNIII subset, the Contactin1 and the Contactin2 glycoproteins, thanks to the use of <italic>in vitro</italic> models (<xref ref-type="bibr" rid="B90">Ranscht, 1988</xref>; <xref ref-type="bibr" rid="B34">Gennarini et al., 1989</xref>; <xref ref-type="bibr" rid="B31">Furley et al., 1990</xref>). These studies indicated that differential activation of the underlying genes during either early or, respectively, late ontogenesis may contribute to their specific ontogenetic function. Accordingly, changes in the profiles of such genes may result in morphogenetic consequences in regions provided with different developmental history, including the cerebellar and cerebral cortices (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>, <xref ref-type="bibr" rid="B11">2015</xref>), the basal ganglia (<xref ref-type="bibr" rid="B71">Massaro et al., 2012</xref>), and the hippocampus (<xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>, <xref ref-type="bibr" rid="B87">2015</xref>). In addition, these changes may sustain the pathogenesis of specific neurological disorders, typically shown in the case of the autism (<xref ref-type="bibr" rid="B123">Zuko et al., 2011</xref>, <xref ref-type="bibr" rid="B124">2013</xref>) and of some dysmyelinating neuropathies (<xref ref-type="bibr" rid="B89">Querol et al., 2013</xref>; <xref ref-type="bibr" rid="B68">Manso et al., 2016</xref>).</p>
<p>The above evidences support the relevant significance of the mechanisms, which drive regulated expression of Contactin axonal morphoregulatory molecules in nervous tissue differentiation and patterning. A remarkable example in this respect is provided by the molecular interactions of the Contactin1 adhesive glycoprotein, which, besides further adhesion molecules (<xref ref-type="bibr" rid="B36">Gennarini and Furley, 2017</xref>; <xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>), may also involve the products of developmental control genes. Among them a special functional and developmental significance has been assigned to the Contactin1 interactions with Notch receptors (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>; <xref ref-type="bibr" rid="B121">Zhang et al., 2018</xref>), which, during nervous tissue patterning, may be mostly relevant for modulating key developmental events as axonal growth and pathfinding, typically shown in cerebellar (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>) and cerebral (<xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>) cortices and in the hippocampus (<xref ref-type="bibr" rid="B39">Gulisano et al., 2017</xref>), the latter also involving modulation of the expression of the pCREB transcription factor (<xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>, <xref ref-type="bibr" rid="B87">2015</xref>). Therefore, via differential molecular interactions (with Notch and/or pCREB), the same morphoregulatory molecule may exert a complex and articulated control on either early or, respectively, late neural development, thus strengthening the relevance of the mechanisms, which drive the regulated expression of the underlying genes.</p>
<p>The present study will focus on such molecular interactions, but also on the associated signaling pathways, which, again, may be activated during both early and late developmental stages. In addition, a special emphasis will be on the significance of components of the dietary intake, and in particular, on polyphenols, given their ability to modulate neurogenesis (<xref ref-type="bibr" rid="B115">Valenti et al., 2016</xref>; <xref ref-type="bibr" rid="B22">Ding et al., 2017</xref>; <xref ref-type="bibr" rid="B86">Poulose et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Bensalem et al., 2018</xref>; <xref ref-type="bibr" rid="B98">Sarubbo et al., 2018</xref>). Indeed, in the nervous tissue, relevant polyphenol effects are demonstrated during development, but also during aging (<xref ref-type="bibr" rid="B7">Bensalem et al., 2018</xref>) and in those conditions characterized by tissue damage (<xref ref-type="bibr" rid="B91">Renno et al., 2017</xref>), consistent with their demonstrated ability to support phenotype recovery in neurodegenerative/neurodevelopmental disorders (<xref ref-type="bibr" rid="B111">Syarifah-Noratiqah et al., 2018</xref>). On a mechanistic ground, these effects may be related to the polyphenols antioxidant activity (<xref ref-type="bibr" rid="B56">Lalkovièová and Danielisová, 2016</xref>), thus supporting the ability of such compounds and of the downstream pathways to exert neurotrophic effects (<xref ref-type="bibr" rid="B74">Moosavi et al., 2015</xref>). In this respect, a typical example is provided by grape seed polyphenols (GSP), whose ability to promote neural regeneration has been demonstrated in different studies (<xref ref-type="bibr" rid="B41">He et al., 2017</xref>; <xref ref-type="bibr" rid="B91">Renno et al., 2017</xref>; <xref ref-type="bibr" rid="B94">Ruzicka et al., 2018</xref>), as specifically shown in the case of the developmental events of cochlear hair cells (<xref ref-type="bibr" rid="B38">Gu et al., 2015</xref>). The polyphenol antioxidant activity may therefore represent a relevant and appropriate therapeutic tool toward the mentioned conditions (<xref ref-type="bibr" rid="B1">Abolhassani et al., 2017</xref>; <xref ref-type="bibr" rid="B3">Ahmed et al., 2017</xref>; <xref ref-type="bibr" rid="B2">Aguilera et al., 2018</xref>).</p>
<p>Polyphenols are ubiquitously distributed, as they are present in fruits, vegetables, cereals, and extra virgin olive oil (<xref ref-type="bibr" rid="B61">Magrone and Jirillo, 2018</xref>). Chemically, they may be divided into two major classes, flavonoids and non-flavonoids (e.g., resveratrol), which may exert their biological functions in different tissues and organs, including the nervous and the immune systems, in which they control the peripheral immune response on both the innate or the adaptive arms of the immune machinery (<xref ref-type="bibr" rid="B66">Magrone et al., 2007</xref>, <xref ref-type="bibr" rid="B59">2008a</xref>). In the immune system these compounds are known to counteract the NF-κB pathway and as such they may induce a tolerogenic anti-inflammatory pathway as demonstrated either <italic>in vitro</italic> or <italic>in vivo</italic> (<xref ref-type="bibr" rid="B60">Magrone et al., 2008b</xref>, <xref ref-type="bibr" rid="B63">2017a</xref>; <xref ref-type="bibr" rid="B70">Marzulli et al., 2014</xref>). Within the central nervous system (CNS), polyphenol anti-oxidant and anti-inflammatory effects should be taken into account, according to their mentioned capacity to promote an immune tolerogenic pathway (<xref ref-type="bibr" rid="B62">Magrone et al., 2012</xref>, <xref ref-type="bibr" rid="B65">2017b</xref>). In Parkinson’s disease (PD) neuronal damage mediated by 5-S-cysteinyldopamine is markedly attenuated by quercetin, hesperetin and caffeic acid, which are derivatives of catechin and epigallocatechin (<xref ref-type="bibr" rid="B67">Mandel and Youdim, 2004</xref>; <xref ref-type="bibr" rid="B105">Spencer, 2009</xref>). Moreover, quercetin anti-inflammatory effects on glial cells also prevent neuronal death (<xref ref-type="bibr" rid="B46">Hunot and Hirsch, 2003</xref>; <xref ref-type="bibr" rid="B104">Spencer, 2007</xref>). The polyphenol protective effects against neurodegeneration are consistent with their therapeutic role on specific neurological disorders as is the case for the Alzheimer’s disease (AD) in which they afford neuroprotection <italic>via</italic> activation of brain-derived neurotrophic factor (BDNF). In AD, resveratrol promotes neuroprotection <italic>via</italic> breakdown of the amyloid precursor proteins and removal of neurotoxic Aβ peptides (<xref ref-type="bibr" rid="B20">Deng and Mi, 2016</xref>). In addition, polyphenols may act through the Sirt pathway, whose reduced levels in AD were found to enhance NF-kB expression, thus counteracting inflammation and Aβ toxicity (<xref ref-type="bibr" rid="B4">Almeida et al., 2016</xref>; <xref ref-type="bibr" rid="B32">Gao et al., 2016</xref>). A neuroprotective mechanism may also rely upon the polyphenol ability to counteract expression of granzymes in cytotoxic T cells (Tc), thus preventing neuronal damage by Tcs infiltrating the CNS (<xref ref-type="bibr" rid="B62">Magrone et al., 2012</xref>). Similarly, polyphenols may also induce activation of FoxP3<sup>+</sup> CD4<sup>+</sup> T cells, the so called T regulatory (Treg) cells, which are producers of the anti-inflammatory (IL)-10 interleukin cytokine (<xref ref-type="bibr" rid="B69">Marzulli et al., 2012</xref>; <xref ref-type="bibr" rid="B63">Magrone et al., 2017a</xref>, <xref ref-type="bibr" rid="B64">c</xref>). In turn, Treg cells migrating from periphery to CNS may dampen neuroinflammation in the course of PD and AD, respectively.</p>
<p>Taken together, the above data indicate that polyphenols share in common with IgC2/FNIII molecules the ability to counteract neurodevelopmental delay and neurodegeneration and, based on these considerations, a relevant aim of the present study is to validate the potential significance of IgC2/FNIII molecules cooperation with polyphenols in exerting protective effects against neuronal damage. For this, in the present study transgenic mice undergoing IgC2/FNIII molecules misexpression are used as animal models, in which the potential polyphenol protective effects against neurodegeneration are explored. Both <italic>in vivo</italic> and <italic>in vitro</italic> approaches will be used in this attempt. As for the former, mutant mice undergoing changes in the regulated expression profile of such molecules have been chosen. As for the <italic>in vitro</italic> models rather than primary neural cultures, cell lines of neural derivation have been selected, with reference to the SH-SY5Y neuroblastoma cells, the reason for this being that this cell line has been extensively used in studies focusing on neuronal precursor proliferation and differentiation (see <xref ref-type="bibr" rid="B120">Xie et al., 2010</xref>; <xref ref-type="bibr" rid="B103">Singh et al., 2017</xref>) and, in addition, that using this line is much easier than using primary cultures, while providing comparable information. Moreover, concerning the specific topic of this study, this line was found to undergo differentiation upon polyphenol treatment (<xref ref-type="bibr" rid="B52">Kalfon et al., 2007</xref>) and therefore it represents a useful, quick and inexpensive model for exploring developmental parameters at the cellular level upon polyphenol stimulation.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>In the present study both <italic>in vitro</italic> and <italic>in vivo</italic> models have been used.</p>
<sec id="S2.SS1">
<title><italic>In vitro</italic> Models</title>
<p>The SH-SY5Y neuroblastoma line has been chosen to evaluate the potential effects of polyphenol administration on the neuronal phenotype. This cell line was purchased from ATCC (Manassas, VA, United States) and cultivated at 37°C in Dulbecco’s Modified Eagles Medium (DMEM), supplemented with 10% v/v fetal bovine serum (FBS), containing 1% penicillin/streptomycin and 2 mM L-glutamine in a 5% CO<sub>2</sub> atmosphere. For the attempts of the present study the cells were seeded at an initial density of 10<sup>4</sup>/cm<sup>2</sup>, and cultivated for 24 h before starting polyphenols treatment, which consisted in red grape extract (GSP) addition to the cultures (see below).</p>
<sec id="S2.SS1.SSS1">
<title>Polyphenol Treatment</title>
<p>As for the polyphenol source, dry extracts containing both proanthocyanidins and catechins were courtesy provided by Farmalabor s.r.l. (Canosa di Puglia, Italy). GSP were extracted from <italic>Vitis vinifera</italic> grape cultivar (Apulia, South Italy) by percolation with ethanol:water (70:30). They were added to SH-SY5Y cell cultures to final concentrations from 1 to 100 μg/ml in the medium, starting from a 1 mg/ml stock in DMSO. The lowest concentration affecting the growth rate was established by building a dose-dependent curve in which the GSP effects on SH-SY5Y cells proliferation were measured by the MTT assay (<xref ref-type="bibr" rid="B37">Giordano et al., 2011</xref>) over 3 days treatments.</p>
</sec>
<sec id="S2.SS1.SSS2">
<title>Cell Growth Rate Estimation</title>
<p>SH-SY5Y cells were originally maintained as frozen stocks or as stocks of living cells. To estimate the effects of GSP administration on their proliferation/differentiation parameters they were seeded on 18 mm coverslips in six wells plates and GSP was then added to the medium 24 h later. At different time points (1, 2, 3, 5, 7, and 12 days) the number of viable cells was estimated through a trypan blue exclusion test and expressed as the percentage of the value observed in controls.</p>
</sec>
<sec id="S2.SS1.SSS3">
<title>Time Course of Cell Cycle Progression</title>
<p>To follow the time course of cell cycle progression over the indicated time lapse, cell proliferation was evaluated through different cell cycle markers. GSP was added to the medium 24 h after plating at a 1 μg/ml while BrdU was added at a 20 μM concentration. Cells were then incubated for 2 h, washed, fixed by 4% paraformaldehyde (PFA) and finally saturated in PBS/2% milk for 1 h at RT. The coverslips were then incubated with BrdU antibodies (mouse monoclonal, Roche Molecular Biochemicals, Mannheim, Germany), overnight at 4°C and with primary antibodies against p27<sup>kip1</sup> (mouse monoclonal, BD Biosciences, San Jose, CA), Cyclin E (rabbit polyclonal, Abcam, Cambrige, MA, United States), β-tubulin (mouse monoclonal, Novus Biologicals, Centennial, CO, United States), followed by secondary antibodies coupled to Alexa Fluor 488 or 568 (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, United States). Nuclei were counterstained with DAPI and, after immunostaining, cells were examined by a TCS SP8 confocal laser-scanning microscope (Leica Microsystems, Wetzlar, Germany) through a sequential procedure. Confocal images were taken at 1 μm intervals through the <italic>Z</italic>-axis of the sections at a 20× magnification and Z-stacks of serial optical planes were then analyzed by a Leica confocal software (Multicolour Package, Leica Microsystems).</p>
<p>Labeled cells were automatically counted by using the ImageJ software (<xref ref-type="bibr" rid="B100">Schneider et al., 2012</xref>) and their density expressed as their percentage toward the overall cell number, estimated by DAPI staining. The corresponding images were digitized, optimized by contrast enhancement functions and segmented by an interactive modality of the program. For the different markers, the program also allowed to select the same threshold for each group. Quantitative estimation of neuronal precursor commitment/differentiation, as well as histomorphometric measurements were similarly done on immunostained slides. The resulting binary images were then processed by functions of the Neurite Tracer plug-in program allowing measurement of neurite growth (<xref ref-type="bibr" rid="B85">Pool et al., 2008</xref>).</p>
</sec>
</sec>
<sec id="S2.SS2">
<title><italic>In vivo</italic> Models</title>
<p>Developmental parameters were also studied <italic>in vivo</italic> in the cerebellar cortex, in which the GSP effects were explored in wild type (WT) or, alternatively, in TAG/F3 transgenic mice, undergoing Contactin1 developmental overexpression under control of the Contactin2 promoter (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>). The generation and use of this line have been described (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>, <xref ref-type="bibr" rid="B11">2015</xref>; <xref ref-type="bibr" rid="B16">Coluccia et al., 2004</xref>; <xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>, <xref ref-type="bibr" rid="B87">2015</xref>). TAG/F3 mice were maintained as heterozygotes and time-pregnant littermates were used throughout, the day of vaginal plug being considered as the embryonic day 0 (E0). For polyphenols, a mice diet consisting in food mixed with grape seed extracts (92.5 mg of polyphenols/gr of food), was administered <italic>ad libitum</italic>. Mice fed in the absence of grape extract were used as the controls. The treatment begun during the embryonic life by GSP administration to the pregnant mothers; polyphenol-containing or control diets were then maintained until the end of the first postnatal week when the animals were sacrificed for examination. At each developmental stage, the study included four groups of mice: WT and transgenic (TAG/F3), fed with either conventional or supplemented food.</p>
<sec id="S2.SS2.SSS1">
<title>Immunostaining</title>
<p>For immunohistochemical procedures, mice perfused with 4% PFA in 0.12M phosphate buffer (PB) pH 7.4 were dissected and the tissues were post-fixed overnight in the same fixative. Twelve micrometers cryostat sections were then generated and immunostainings were done on sagittal sections from the cerebellar vermis, whose derivation along the medio-lateral axis was deduced upon comparison with adjacent structures. For the <italic>in vitro</italic> data, cultures from the SH-SY5Y human neuroblastoma line were similarly fixed and immunostained as above.</p>
<p>For Contactin1 immunostaining, the LIM antiserum, raised in rabbits against the 20 N-terminal amino acid sequence of the molecule and reproducing its expression profile (<xref ref-type="bibr" rid="B116">Virgintino et al., 1999</xref>; <xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B9">2009</xref>, <xref ref-type="bibr" rid="B10">2012</xref>; <xref ref-type="bibr" rid="B19">De Benedictis et al., 2006</xref>) or, alternatively, a mouse monoclonal Contactin1 antibody (Chemicon, Temecula, CA) were used. Contactin2 was detected through a rabbit antiserum (<xref ref-type="bibr" rid="B24">Dodd et al., 1988</xref>) and NeuN through a mouse monoclonal antibody from Chemicon. As for Hes-1, a rabbit antiserum was obtained from Abcam.</p>
<p>To estimate precursor proliferation <italic>in vivo</italic>, mice were intraperitoneally injected with 5-bromo-2′-deoxyuridine (BrdU, Roche Molecular Biochemicals, Mannheim, Germany, 50 ug/g body weight) and sacrificed 5 days later when BrdU was detected through a sheep antiserum from Novus Biologicals.</p>
<p>For immunostaining, the same section thickness, antibody concentrations, incubation time, developing conditions, microscopic pictures acquisition and handling procedures were applied at all developmental stages. Sections permeabilized for 30′ at RT with 0.5% Triton X-100, 3% BSA, 5–10% FCS were incubated ON at 4°C with primary antibodies diluted in PBS containing 3% BSA, 5–10% FCS and 0.25% Triton X-100, followed by secondary antibodies (1 h incubation at RT).</p>
<p>Immunostained sections were analyzed by using a TCS SP8 confocal laser-scanning microscope (Leica) through a sequential scanning procedure. Confocal images were taken at 1 μm intervals through the <italic>z</italic>-axis of the sections with 20× or 40× lenses. Z-stacks of serial optical planes were analyzed by a Leica confocal software (Multicolour Package, Leica Microsystems). BrdU- and NeuN-labeled cells were automatically counted by the ImageJ software, and their density expressed as their percentage over the overall cell number, estimated by DAPI staining. Histomorphometric measurements for Hes-1, Contactin1, Contactin2, and NeuN were done on selected corresponding sections by the ImageJ software. Corresponding images were digitized, optimized by contrast enhancement functions and segmented by an interactive modality of the program. For each marker, the program also allowed to select the same threshold for each group. The resulting binary images were then processed by functions allowing measurement of the extent of the immunostaining, deduced by the pixel number.</p>
</sec>
<sec id="S2.SS2.SSS2">
<title>Animal Breeding</title>
<p>Mice were bred in the Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Aldo Moro, Italy and experimentation conformed the EU directive 2010/63/EU by following the Italian Ministry of Health law of March 4, 2014, n. 26 upon the Authorization n. 982/2016 released from the Italian Ministry of Health on October 17, 2016, which also included the ethical approval of the proposed research from the “Organism in charge of animal welfare” of the Bari University.</p>
</sec>
<sec id="S2.SS2.SSS3">
<title>Statistical Analyses</title>
<p>All experiments were performed in triplicate and repeated at least three times. In order to identify statistically relevant data, the differences were evaluated by ANOVA tests or by the Student’s <italic>t</italic> test. The mean values ± standard error mean (SEM) were calculated to represent the three experiments. A <italic>p</italic>-value &lt; 0.05 was considered statistically significant. As for the distribution of the obtained data, this was explored by using the GraphPad program, which also allowed <italic>P</italic> values correction.</p>
<p>As for the <italic>in vitro</italic> experiments aiming at following cell cycle progression (BrdU incorporation, Cyclin E, p27 Kip expression) or neuronal differentiation (β-tubulin expression), the data were expressed as the mean and the SEM. Such data approached a Gaussian distribution and respected assumptions for parametric tests, so that comparisons between independent groups were performed by <italic>t</italic>-tests. Each measure was repeated at the different days and adjustments for multiple testing were applied according to Bonferroni. In experiments implying dose-dependent effects a one-way ANOVA test was used, while two-way ANOVA was chosen for cell growth rate measures. The following variables: “cerebellar size,” “NeuN,” “Contactin2,” and “BRDU” approached a Gaussian distribution and a linear model; therefore a two way factorial ANOVA model with interaction was applied to evaluate the effects of treatment (treated vs. control) and gene expression (WT vs. TAG/F3) and their interaction. Results were described as least square means and their 95% confidence intervals. <italic>P</italic>-values for <italic>post hoc</italic> comparisons were adjusted according to Tukey.</p>
<p>Contactin1 expression did not approach a Gaussian distribution and diverge from a linear model, therefore data were summarized as median and 95% confidence interval of the median. Since, we had two factors (gene expression and polyphenol treatment) with two levels, as previously described for other variables, we needed to perfom, by Mann–Whitney <italic>U</italic> test, eight pairs comparisons of indipendent groups. Given the multiple testing procedure, to conclude about effects of treatment and of transgene expression <italic>p</italic>-values were adjusted according to Bonferroni.</p>
</sec>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title><italic>In vitro</italic> and <italic>in vivo</italic> Models for Studying the Neurodevelopmental Consequences of Contactin1 Overexpression and of Polyphenol Administration</title>
<p>This study includes two distinct, although overlapping sections, dealing, respectively with <italic>in vitro</italic> and <italic>in vivo</italic> approaches for exploring the significance of adhesive glycoproteins expression profile and of polyphenol administration in the control of nervous tissue developmental events. First the <italic>in vitro</italic> results obtained in the SH-SY5Y neuronal cell line will be reported. Then the <italic>in vivo</italic> data arising in transgenic mice undergoing Contactin1 developmental overexpression driven from the regulatory region of the gene encoding the Contactin2 glycoprotein (also called Transient Axonal Glycoprotein TAG-1, <xref ref-type="bibr" rid="B31">Furley et al., 1990</xref>), the TAG/F3 transgenic line (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), will be discussed.</p>
<p>In the SH-SY5Y neuronal cell line (<xref ref-type="bibr" rid="B18">Cuevas et al., 2015</xref>; <xref ref-type="bibr" rid="B96">Saeed et al., 2015</xref>; <xref ref-type="bibr" rid="B122">Zheng et al., 2015</xref>) the effects of GSP on proliferation/commitment/differentiation parameters, as well as on cell death, were originally estimated. SH-SY5Y cells have been extensively used in studies aiming at evaluating neuronal precursor proliferation and differentiation parameters (see <xref ref-type="bibr" rid="B120">Xie et al., 2010</xref>). Moreover, as far as the specific topic of this study is concerned, previous studies demonstrated that this cell line undergoes differentiation upon polyphenol treatment (<xref ref-type="bibr" rid="B52">Kalfon et al., 2007</xref>) and as such it represents an useful tool for exploring developmental parameters at the cellular level. Finally, a relevant advantage of focusing on this line rather than on primary neurons is on its ability to undergo large-scale expansion upon relatively easy culture conditions (<xref ref-type="bibr" rid="B119">Xicoy et al., 2017</xref>). For such an <italic>in vitro</italic> approach, cells bearing the N-type morphology were used, which allowed exploring their phenotype in terms of developmental events, mostly related to neuronal differentiation.</p>
<p>As indicated the <italic>in vivo</italic> developmental significance of the Contactin adhesion molecules expression profile was explored by using the TAG/F3 transgenic line (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>), which undergoes Contactin1 overexpression and premature expression under control of the Contactin2 gene (<italic>CNTN-2</italic>) promoter. Previous studies revealed that expressing the TAG/F3 transgene in developing nervous tissue resulted into an ontogenetic delay, mostly evident in the cerebellum (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), in the cerebral cortex (<xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), in the basal ganglia (<xref ref-type="bibr" rid="B71">Massaro et al., 2012</xref>) and in the early developing hippocampus (<xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>, <xref ref-type="bibr" rid="B87">2015</xref>). As for the underlying mechanisms, these effects could be attributed to the Contactin1 ability to activate the Notch pathway (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>, <xref ref-type="bibr" rid="B45">2006</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), known to result into a neurodevelopmental delay (<xref ref-type="bibr" rid="B121">Zhang et al., 2018</xref>). In the same context, Contactin1-overexpressing mice provided a suitable model to explore the ability of polyphenol administration in counteracting neurodevelopmental delay. In addition, this transgenic line was especially useful for exploring the molecular mechanisms underlying neuronal differentiation, with reference in particular to genetic (adhesion molecules expression) and epigenetic (polyphenol administration) factors. Therefore, in the proposed experimental models, the significance of different factors, known to modulate neural developmental events was evaluated by the use of either <italic>in vitro</italic> and <italic>in vivo</italic> approaches as reported below.</p>
<sec id="S3.SS1.SSS1">
<title><italic>In vitro</italic> Approach: The SH-SY5Y Cell Line</title>
<p>The transformed neuron-like cell line of human derivation SH-SY5Y (ATCC-CRL-2266) originates from a metastatic human bone tumor biopsy and represents a subline of the parental SK-N-SH cells, often used in studies focusing on neurodegenerative disorders and aiming at devising therapeutic strategies (<xref ref-type="bibr" rid="B103">Singh et al., 2017</xref>). In the context of the present study, the interest of this poorly differentiated line was also based on the evidence that it can be driven into a more mature phenotype upon polyphenol treatment (<xref ref-type="bibr" rid="B52">Kalfon et al., 2007</xref>). Therefore, a preliminary characterization of the proliferation/differentiation parameters of the SH-SY5Y line upon polyphenol treatment was done.</p>
<sec id="S3.SS1.SSS1.Px1">
<title>Effects of GSP treatment on SH-SY5Y cell phenotype</title>
<p>To look at the best working conditions for polyphenol treatment, a dose-dependent curve of SH-SY5Y cell proliferation was first established by estimating their growth profile upon increasing GSP concentration in the medium (1–100 μg/ml upon 3 days treatment steps). As shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>, increasing the GSP input resulted into a reduced SH-SY5Y cell proliferation, expressed as the percentage of control cells, which was virtually abolished when GSP concentrations exceeding 50 μg/ml were reached, these data indicating inhibitory GSP effects on SH-SY5Y cell proliferation.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>GSP treatment affects SH-SY5Y cells proliferation and survival. <bold>(A)</bold> SH-SY5Y cell proliferation: treatment for 72 h induced a GSP concentration-dependent reduction of SH-SY5Y cell proliferation, deduced by the cell density and measured through the MTT assay. For statistical analysis a one-way ANOVA test was used: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001. Values are expressed as mean ± SEM. <bold>(B)</bold> SH-SY5Y cell survival: GSP treatment affected cell viability by inducing a dose-dependent increase in the number of dead cells. Low doses (1–5 μg/ml) led to only minor effects while high doses (75–100 μg/ml) were toxic, resulting in dose-dependent cell death. Dead cells were detected by Trypan blue exclusion tests. Values represent averages of triplicate measurements. As in panel <bold>(A)</bold>, statistical analysis was performed by using one-way ANOVA test: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗</sup><italic>p</italic> &lt; 0.001; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g001"></graphic>
</fig>
<p>To verify whether apoptosis contributed to these effects, the number of dead cells was also estimated through a Trypan Blue exclusion test upon an increasing GSP input. As shown in <xref ref-type="fig" rid="F1">Figure 1B</xref>, increasing polyphenol concentrations from 1 to 100 μg/ml significantly expanded the number of dead cells, indicating that, besides exerting anti-proliferative activity, GSP also affected cell survival, thus leading to cell loss. For the statistical evaluation of all the above data a one-way ANOVA test was used.</p>
</sec>
<sec id="S3.SS1.SSS1.Px2">
<title>Cell growth rate</title>
<p>The time course of SH-SY5Y cell proliferation was also deduced through the overall number of viable cells in a wider time lapse (1–12 days) in the presence/absence of GSP in the medium (1 μg/ml concentration). As shown in <xref ref-type="fig" rid="F2">Figure 2</xref>, starting at the third day of treatment, a significant decrease in viable cells was observed in GSP-treated versus control samples by a trypan-blue exclusion test, thus supporting that an effect on cell viability contributed to the observed phenotype. For these data two way ANOVA test and Dunnet’s multiple comparison test were used.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>GSP treatment counteracts SH-SY5Y neuroblastoma cell growth. Cell growth was determined by estimating the number of viable cells by a Trypan Blue exclusion test at days 1, 2, 3, 5, 7, and 12 after plating. At each developmental stage, the data are representative of at least three experiments. Values are expressed as the mean ± SEM. Statistical analysis was done through a two-way ANOVA test: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g002"></graphic>
</fig>
</sec>
<sec id="S3.SS1.SSS1.Px3">
<title>Cell cycle progression</title>
<p>To confirm the contribution of changes in precursor proliferation to the overall cell number, cell cycle progression was also explored through cell cycle markers expression, known to be modulated by polyphenol administration and to result in specific effects on cell cycle exit at the G1 phase, in particular at the level of G2/M interphase transition (<xref ref-type="bibr" rid="B102">Shin et al., 2013</xref>). To explore these parameters the GSP effects on cell cycle were evaluated through the expression of p27<sup>kip1</sup>, a kinase inhibitory protein (KIP) family member known to drive precursors toward G0 at the G1/S interphase (<xref ref-type="bibr" rid="B84">Polyak et al., 1994</xref>; <xref ref-type="bibr" rid="B43">Hnit et al., 2015</xref>). Based on the reported time course for cell growth (<xref ref-type="fig" rid="F2">Figure 2</xref>), 3, 5, and 7 days cultures were analyzed. At these time points p27<sup>Kip1</sup> levels were morphometrically estimated and expressed as the p27<sup>Kip1</sup>/DAPI ratio. The data indicated a 140% p27<sup>Kip1</sup> increase at 3 days (<xref ref-type="fig" rid="F3">Figure 3A</xref>, adjusted <italic>p</italic> = 0.0045), a 128% value at 5 days (<xref ref-type="fig" rid="F3">Figure 3B</xref>, adjusted <italic>p</italic> = 0.0399) and a 122% value at 7 days (<xref ref-type="fig" rid="F3">Figure 3C</xref>, adjusted <italic>p</italic> = 0.0471). In all cases, the results indicated statistically significant data.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>GSP treatment promotes SH-SY5Y neuroblastoma cell cycle exit. Cell cycle exit of SH-SY5Y cells was measured through the expression of the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup>. In panels <bold>(A–C)</bold>, double stainings for p27<sup>Kip1</sup> and DAPI are reported in GSP-treated <bold>(ii)</bold> versus control <bold>(i)</bold> cells upon 3 <bold>(A)</bold>, 5 <bold>(B)</bold>, and 7 <bold>(C)</bold> days in culture. The bar graphs shown in panels <bold>(A–C,iii)</bold> report the p27<sup>Kip1</sup>/DAPI ratio in both conditions. The data are representative of at least three experiments and are expressed as the mean ± SEM. Statistical analysis was done through a <italic>t</italic>-test: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗</sup><italic>p</italic> &lt; 0.001. Scale bars: 20 μm.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g003"></graphic>
</fig>
<p>The polyphenol effects on cell cycle progression were also evaluated during the G1 phase of the cell cycle through the expression of Cyclin E, a marker of the G1/S transition (<xref ref-type="fig" rid="F4">Figure 4</xref>) and by BrdU incorporation, which labels cells in the S phase (<xref ref-type="fig" rid="F5">Figure 5</xref>). Expression of the above markers was again evaluated through the number of labeled versus the overall cell number (estimated by DAPI staining) before comparing the different conditions. At 3 days, Cyclin E expressing cells were 77% in treated versus control samples (<xref ref-type="fig" rid="F4">Figure 4A</xref>, adjusted <italic>p</italic> = 0.0273), which at 5 days become 46% (<xref ref-type="fig" rid="F4">Figure 4B</xref>, adjusted <italic>p</italic> = 0.0003), and at 7 days 65% (<xref ref-type="fig" rid="F4">Figure 4C</xref>, adjusted <italic>p</italic> = 0.0286).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>GSP treatment counteracts Cyclin E expression in SH-SY5Y neuroblastoma cells. SH-SY5Y Neuroblastoma cell proliferation was evaluated through expression of cyclin E, reported in the absence (Ctrl, <bold>i</bold>) or in the presence of GSP (GSP, <bold>ii</bold>) upon 3 <bold>(A)</bold>, 5 <bold>(B)</bold>, and 7 <bold>(C)</bold> days of treatment. In panels <bold>(A–C,iii)</bold>, the bar graphs compare the Cyclin E/DAPI ratio in the above conditions. The data are representative of at least three experiments, and values are expressed as the mean ± SEM. Statistical analysis was done through a <italic>t</italic>-test: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001. Scale bars: 20 μm.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g004"></graphic>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>GSP treatment counteracts BrdU incorporation in SH-SY5Y neuroblastoma cells. BrdU incorporation is reported in GSP-treated (GSP, <bold>ii</bold>) versus control (Ctrl, <bold>i</bold>) SH-SY5Y cells upon 3 <bold>(A)</bold>, 5 <bold>(B)</bold>, and 7 <bold>(C)</bold> days of treatment. Bar graphs <bold>(A–C,iii)</bold> compare the number of double BrdU/DAPI labeled cells in both conditions upon 3 <bold>(Aiii)</bold>, 5 <bold>(Biii)</bold>, and 7 <bold>(Ciii)</bold> days of treatment. Data are representative of at least three experiments and the values report the mean ± SEM. For statistical analysis a <italic>t</italic>-test was used: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001. Scale bars: 20 μm.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g005"></graphic>
</fig>
<p>In <xref ref-type="fig" rid="F5">Figure 5</xref>, the extent of BrdU labeling on proliferating cells is shown at the different incubation times (3, 5, and 7 days). The percentage BrdU labeled cells in GSP-treated versus control cells was 66% in 3 day cultures (<xref ref-type="fig" rid="F5">Figure 5A</xref>, adjusted <italic>p</italic> = 0.0003) while at 5 days a higher percentage (77.6%) was observed (<xref ref-type="fig" rid="F5">Figure 5B</xref>, adjusted <italic>p</italic> = 0.018) and a 66.0% value was again observed at 7 days (<xref ref-type="fig" rid="F5">Figure 5C</xref>, adjusted <italic>p</italic> = 0.047). In all cases Bonferroni corrected <italic>p</italic>-values were used.</p>
<p>Statistically significant decreases of both markers were therefore demonstrated in GSP-treated versus control cells, thus indicating inhibitory effects of GSP on cell cycle transition (<xref ref-type="fig" rid="F4">Figures 4Aiii,Biii,Ciii</xref>, <xref ref-type="fig" rid="F5">5Aiii,Biii,Ciii</xref>).</p>
</sec>
<sec id="S3.SS1.SSS1.Px4">
<title>Analysis of the neuronal phenotype</title>
<p>The effects on Cyclin E expression and on BrdU incorporation were both congruent with the observed changes in p27<sup>Kip1</sup> expression as they indicated increased cell cycle exit and reduced proliferation of GSP-treated cells. These data, then, predicted positive effects on neuronal precursor commitment. To confirm this possibility, differentiation along the neuronal lineage was estimated through the expression of β-tubulin and by morphometrically measuring neurite length through the NeuriteTracer, an ImageJ plug-in: the arising data were then statistically evaluated through the Student’s <italic>t</italic>-test. As shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, GSP treatment resulted in a faint, although detectable increase in neurite length in treated versus control cells already in 3 and in 5 days old cultures (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>). On the other hand, sharper effects were observed at 7 days, when a 180% (adjust <italic>p</italic> = 0.03) increase in neurite elongation confirmed the positive effects of GSP treatment along neuronal lineage differentiation (<xref ref-type="fig" rid="F6">Figure 6C</xref>). The above data clearly indicated a relevant increase in the differentiation/proliferation ratio of SH-SY5Y cells as a consequence of GSP treatment. Based on the above findings it could then be inferred that in a cell line of neuronal derivation, GSP treatment promoted the differentiated phenotype while counteracting proliferation.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Neuroblastoma differentiation is promoted by GSP treatment. Neuroblastoma cell differentiation along the neuronal lineage is demonstrated through expression of the NeuN neuronal marker in GSP-treated <bold>(ii)</bold> versus control <bold>(i)</bold> SH-SY5Y cells upon 3 <bold>(A)</bold>, 5 <bold>(B)</bold>, and 7 <bold>(C)</bold> days of treatment. Neuronal differentiation was deduced by measuring neurite lengths in SH-SY5Y cells in GSP-treated <bold>(ii)</bold> versus control <bold>(i)</bold> cells. In panels <bold>(A–C,iii)</bold>, bar graphs compare neurite length in cells treated with GSP versus control cells for 3 <bold>(Aiii)</bold>, 5 <bold>(Biii)</bold>, and 7 <bold>(Ciii)</bold> days. Data are representative of at least three experiments, and values are expressed as the mean ± SEM. For statistical analysis a <italic>t</italic>-test was used: <sup>*</sup><italic>p</italic> &lt; 0.05. Scale bars: 20 μm.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g006"></graphic>
</fig>
<p>To confirm this trend an available <italic>in vivo</italic> model of developmental delay was chosen, which consisted in the mentioned TAG/F3 transgenic line (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), in which the effects of GSP treatment on nervous tissue (cerebellar) development were explored.</p>
</sec>
</sec>
<sec id="S3.SS1.SSS2">
<title><italic>In vivo</italic> Approach: Polyphenol Effects on Cerebellar Development of Contactin1-Overexpressing Transgenic Versus Control Mice</title>
<p>To explore the polyphenol effects on cerebellar development, the phenotypes of TAG/F3 and WT mice in the presence and in the absence of GSP were compared at P0 and P8, when the overall cerebellar size, as well as the expression of proliferation/differentiation markers were morphometrically estimated. As for the cerebellar size, in newborn mice no significant differences were observed in this parameter in either genotype in polyphenol-treated versus control mice (<xref ref-type="fig" rid="F7">Figure 7A</xref>, compare i with ii and iii with iv and <xref ref-type="fig" rid="F7">Figure 7Ci</xref>). At postnatal day 8, previous studies performed over a developmental window spanning the first postnatal week revealed a developmental delay in TAG/F3 versus WT mice (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), which could be deduced from the reduced surface of cerebellar sections. In the present study, such an effect was confirmed, with a consistent reduction of the cerebellar size at P8 in TAG/F3 mice (<xref ref-type="fig" rid="F7">Figure 7B</xref>, compare i with iii and <xref ref-type="fig" rid="F7">Figure 7Cii</xref>). At this developmental stage, GSP treatment led to an additional reduction in both genotypes (<xref ref-type="fig" rid="F7">Figure 7B</xref>, compare i with ii and iii with iv and <xref ref-type="fig" rid="F7">Figure 7Cii</xref>). The main GSP effects were observed on the WT genotype, while minor although still significant differences could be detected in the TAG/F3 littermates. Indeed, in GSP-treated WT mice a cerebellar size of 64% compared to untreated controls (adjusted <italic>p</italic> &lt; 0.0001) was demonstrated while in TAG/F3 littermates this value accounted to 74% (adjusted <italic>p</italic> &lt; 0.0001). While reflecting reduced cerebellar size in TAG/F3 mice compared to controls (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), these data indicated that at this stage polyphenol treatment exerted lower effects in transgenic mice compared to WT littermates. Overall, these data indicated that Contactin1 overexpression and polyphenol administration both negatively modulated cerebellar size with stronger effects of polyphenols compared to those of Contactin1. This suggested that these effects were exerted through the same pathways and given the Contactin1 ability to activate the Notch pathway (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>, <xref ref-type="bibr" rid="B45">2006</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), that GSP and Contactin1 could exert their effects through such a pathway.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>GSP treatment affects cerebellar size in newborn (P0) and postnatal day 8 (P8) mice. <bold>(A,B)</bold> Toluidine blue-stained sagittal sections from either WT <bold>(i,ii)</bold> and TAG/F3 transgenic <bold>(iii,iv)</bold> mice cerebellum in the absence <bold>(i,iii)</bold> or in the presence <bold>(ii,iv)</bold> of GSP treatment. In panel <bold>(C)</bold>, the result of the morphometric analysis of the stained sections surfaces is reported. The data are the result of the analysis of 40 cerebellar sections from 16 mice arising from either the WT and the TAG/F3 genotypes (8 wt and 8 TAG/F3). <bold>(A)</bold> Low magnification images (5×) arising from WT <bold>(i,ii)</bold> and TAG/F3 <bold>(iii,iv)</bold> newborn mice. Scale bar: 200 μm. <bold>(B)</bold> Low magnification images (2.5×) arising from WT <bold>(i,ii)</bold> and TAG/F3 <bold>(iii,iv)</bold> mice at P8. Scale bar: 500 μm. <bold>(C)</bold> Bar graphs comparing the surface of the cerebellar sections at P0 <bold>(i)</bold> and P8 <bold>(ii)</bold> from either WT and TAG/F3 genotypes in either control (Ctrl) or GSP-treated (GSP) mice, through a two-wayANOVA test. Asterisks indicate statistically significant differences: <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g007"></graphic>
</fig>
<p>To further explore the mechanisms potentially responsible for the reported GSP effects on the cerebellar size, neuronal precursor proliferation and commitment/differentiation were separately evaluated. In the TAG/F3 line, NeuN expression (to estimate Neuronal commitment) and the density of double NeuN/BrdU positive elements (for neuronal commitment of proliferating precursor) were estimated and compared to control mice.</p>
<p>As shown in <xref ref-type="fig" rid="F8">Figure 8</xref>, neuronal commitment, was significantly increased upon polyphenol treatment in both newborn WT (144% adjusted <italic>p</italic> = 0.046) and TAG/F3 (149% adjusted <italic>p</italic> = 0.032) mice (<xref ref-type="fig" rid="F8">Figure 8A</xref>, compare i with ii and iii with iv, and <xref ref-type="fig" rid="F8">Figure 8Ci</xref>). Such a profile was maintained at postnatal day 8, although lower effects of GSP treatment were observed in both WT (120% adjusted <italic>p</italic> = 0.0004) and TAG/F3 (117%, adjusted <italic>p</italic> = 0.0205) mice (<xref ref-type="fig" rid="F8">Figure 8B</xref>, compare i with ii and iii with iv and <xref ref-type="fig" rid="F8">Figure 8Cii</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Cerebellar neurogenesis is promoted in WT <bold>(A,B,i,ii)</bold> and in TAG/F3 <bold>(A,B,iii,iv)</bold> transgenic mice upon GSP treatment, as demonstrated by NeuN immunostaining. Cerebellar sections from either untreated <bold>(i,iii)</bold>, or GSP-treated <bold>(ii,iv)</bold> mice were analyzed upon NeuN immunostaining at both P0 (<bold>A</bold>, 20× magnification, scale bar 40 μm) and P8 (<bold>B</bold>, 40× magnification, scale bar 20 μm). <bold>(C)</bold> Bar graphs showing the results of the morphometric analysis of the immunostaining shown in panels <bold>(A,B)</bold>, reporting the number of NeuN/DAPI positive cells ratio at P0 <bold>(i)</bold> and P8 <bold>(ii)</bold>. Asterisks indicate statistically significant differences: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001 through a two-way ANOVA test.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g008"></graphic>
</fig>
<p>In both WT and TAG/F3 mice the polyphenol effects were also morphometrically estimated on precursor commitment toward the neuronal lineage upon double NeuN-BrdU immunostaining at both P0 and P8 and expressed as the NeuN-BrdU versus BrdU ratio. In newborn WT cerebellum, GSP treatment resulted in positive effects on proliferating precursor commitment toward the neuronal lineage (148%, adjusted <italic>p</italic> = 0.0309; <xref ref-type="fig" rid="F9">Figures 9Ai,ii,Ci</xref>) while very minor, non-significant effects were observed in newborn TAG/F3 mice (<xref ref-type="fig" rid="F9">Figures 9Aiii,iv,Ci</xref>). In postnatal day 8 cerebellum, precursor commitment toward the neuronal lineage was still sharply increased in WT mice (160%, adjusted <italic>p</italic> = 0.036) upon polyphenol treatment (<xref ref-type="fig" rid="F9">Figures 9Bi,ii,Cii</xref>) with sharper effects in TAG/F3 littermates (188%, adjusted <italic>p</italic> = 0.037; <xref ref-type="fig" rid="F9">Figures 9Biii,iv,Cii</xref>).</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Cerebellar precursors neuronal commitment is promoted in newborn and postnatal day 8 WT <bold>(A,B,i,ii)</bold> as well as in P8 <bold>(B,iii,iv)</bold>, but not in newborn <bold>(A,iii,iv)</bold> TAG/F3 mice in GSP treated <bold>(ii,iv)</bold> versus untreated <bold>(i,iii)</bold> controls (Ctrl). The data are deduced in sagittal sections from both genotypes and morphometrically estimated as the ratio of double NeuN-BrdU versus BrdU immunostaining. <bold>(A)</bold> 20× magnification images of P0 cerebellar cortex, scale bar: 40 μm. <bold>(B)</bold> 40× magnification images of P8 cerebellar cortex, scale bar: 20 μm. <bold>(C)</bold> Bar graphs showing the results of the morphometric analysis of the immunostaining shown in panels <bold>(A,B)</bold>, reporting the ratio among the number of double NeuN-BrdU versus BrdU-labeled cells at the selected developmental stages: P0 <bold>(i)</bold> and P8 <bold>(ii)</bold>. Colocalization points are reported in the insets as ImageJ plug-in output. In panel <bold>(C)</bold>, asterisks indicate statistically significant differences: <sup>*</sup><italic>p</italic> &lt; 0.05 through a two-way ANOVA test.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g009"></graphic>
</fig>
<p>These data indicated a general positive effect of GSP treatment on neuronal precursor commitment at both P0 and P8 in WT mice. In TAG/F3 littermates very low non-significant GSP effects were observed in newborn animals while a sharp increase was demonstrated at P8, confirming the generally stimulatory effects of polyphenols on neurogenesis at this stage and in this genotype. Therefore, overall, the data indicated differential polyphenol effects on neurogenesis depending upon the developmental stage and the genetic background, the effects being mostly demonstrated in Contactin 1-overexpressing mice at the end of the first postnatal week. In turn this indicated that at this stage Contactin1 overexpression could promote nervous tissue responsiveness toward polyphenols.</p>
<p>We also wanted to evaluate whether GSP treatment affected Contactin family members (both Contactin1 and Contactin2) expression in the different genotypes. As for Contactin1, at P0 its expression was significantly downregulated in WT (to a 65% value, adjusted <italic>p</italic> = 0.006) and mostly in TAG/F3 (to a 49% value, adjusted <italic>p</italic> = 0.0024) mice upon GSP treatment (<xref ref-type="fig" rid="F10">Figures 10A,Ci</xref>). This indicated general inhibitory effects of such polyphenol on Contactin1 expression, with the strongest effects in TAG/F3 mice, likely reflecting the higher original Contactin1 levels in this line.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Contactin1 expression is counteracted at P0 and P8 in sagittal cerebellar sections from the developing WT <bold>(A,B,i,ii)</bold> and TAG-F3 <bold>(A,B,iii,iv)</bold> mice in the presence (GSP, <bold>ii,iv</bold>) versus the absence (Ctrl, <bold>i,iii</bold>) of GSP treatment. <bold>(A)</bold> 20× magnification images of P0 cerebellar cortex <bold>(i–iv)</bold>. Scale bar: 40 μm. <bold>(B)</bold> 40× magnification images of P8 cerebellar cortex <bold>(i–iv)</bold>. Scale bars: 20 μm. <bold>(C)</bold> Bar graphs showing the results of the morphometric analysis of the immunostaining shown in panels <bold>(A,B)</bold>, reporting the Contactin1 positive pixel per field at the selected developmental stages: P0 <bold>(i)</bold> and P8 <bold>(ii)</bold>. Asterisks indicate statistically significant differences: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗</sup><italic>p</italic> &lt; 0.001 through a two-way ANOVA test.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g010"></graphic>
</fig>
<p>At P8 strong GSP effects were still observed on WT mice (51%, adjusted <italic>p</italic> = 0.0016), while lower, non-significant consequences of the same treatment were observed on TAG/F3 littermates (76%, adjusted <italic>p</italic> = 0.047), likely reflecting the lower endogenous Contactin1 expression at this stage in this genotype as a consequence of developmental delay (see also <xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>) (<xref ref-type="fig" rid="F10">Figures 10Bi,ii,Cii</xref>). In TAG/F3 mice, therefore, the differences were much lower, and provided with lower significance in GSP-treated versus control mice (<xref ref-type="fig" rid="F10">Figures 10Biii,iv,Cii</xref>). Overall, these data indicated that GSP treatment resulted in Contactin1 downregulation in newborn mice irrespective of the genotype.</p>
<p>As shown in <xref ref-type="fig" rid="F11">Figure 11</xref>, similarly to Contactin1, a sharp decrease in Contactin2 expression was observed in newborn cerebellum upon GSP treatment both in WT (60%; adjusted <italic>p</italic> &lt; 0.0001) and TAG/F3 (45%; adjusted <italic>p</italic> = 0.0025) mice (<xref ref-type="fig" rid="F11">Figures 11A,Ci</xref>). At postnatal day 8, a sharp decrease in Contactin2 expression was similarly demonstrated upon GSP treatment in WT mice cerebellum (49%; adjusted <italic>p</italic> &lt; 0.0001) while lower effects were observed in TAG/F3 littermates (78%; adjusted <italic>p</italic> = 0.041) (<xref ref-type="fig" rid="F11">Figures 11B,Cii</xref>).</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>Contactin2 expression is counteracted in sagittal cerebellar sections from developing WT <bold>(A,B,i,ii)</bold> and TAG-F3 <bold>(A,B,iii,iv)</bold> mice in the presence <bold>(ii,iv)</bold> versus the absence <bold>(i,iii)</bold> of GSP. <bold>(A)</bold> 20× magnification of P0 cerebellar cortex. Scale bars: 40 μm. <bold>(B)</bold> 40× magnification of the P8 cerebellar cortex. Scale bars: 20 μm. <bold>(C)</bold> Bar graphs showing the results of the morphometric analysis of the immunostaining shown in panels <bold>(A,B)</bold>, reporting the area of Contactin2 positive pixel per field at P0 <bold>(i)</bold> and P8 <bold>(ii)</bold>. Asterisks indicate statistically significant differences: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗</sup><italic>p</italic> &lt; 0.01; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.001 through a two-way ANOVA test.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g011"></graphic>
</fig>
<p>Therefore, although at different extents, the expression of Contactin1 and Contactin2 were both downregulated as a consequence of GSP treatment in WT and TAG/F3 mice. Sharper effects were found to occur for both Contactins at P0 while lower consequences were observed for Contactin2 at P8 in TAG/F3 mice, likely reflecting its lower expression levels at this stage in this genotype.</p>
<sec id="S3.SS1.SSS2.Px1">
<title>Relationships between contactins expression and notch pathway activation</title>
<p>As anticipated, besides by its canonical ligands, the Notch pathway may be also activated by adhesion molecules of the IgSF and in particular by components of its Contactin subset, typically shown in the case of Contactin1 (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>). Therefore, in the present study, Notch pathway activation was estimated through the Hes-1 transcription factor expression profile and compared in WT and TAG/F3 mice upon GSP administration (<xref ref-type="fig" rid="F12">Figure 12A</xref>). Morphometric analysis revealed that, irrespective of the genotype, GSP treatment resulted in a sharp Hes-1 and therefore Notch pathway downregulation in both genotypes, with in particular a 32% in WT GSP treated (adjusted <italic>p</italic> &lt; 0.0001) compared to control mice, while this percentage was raised to 35% in TAG/3 littermates (adjusted <italic>p</italic> = 0.021) (<xref ref-type="fig" rid="F12">Figure 12B</xref>). In addition, comparing the consequences of the GSP administration and of Contactin1 expression revealed that the two conditions resulted in similar effects (<xref ref-type="fig" rid="F12">Figure 12B</xref>). Finally, such effects were found to be cumulative, strongest effects being observed in TAG/F3 mice upon GSP treatment. Given that Contactin1 effects on neurogenesis are known to imply Notch pathway activation, a likely explanation could be that GSP treatment exerted its effects by counteracting Contactin1 expression and as such Notch pathway activation.</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption>
<p>Expression of the Hes-1 transcription factor is counteracted by polyphenol (GSP) treatment in cerebellar sections from WT and TAG/F3 mice cerebellum. <bold>(A)</bold> Hes-1 transcription factor expression in sagittal sections from the developing cerebellum from WT <bold>(i,ii)</bold> and TAG/F3 <bold>(iii,iv)</bold> mice upon GSP treatment <bold>(ii,iv)</bold> versus control <bold>(i,iii)</bold> conditions, shown in 20× magnification images. Scale bar: 40 μm. <bold>(B)</bold> Bar graphs showing the results of the morphometric analysis of the immunostaining shown in panel <bold>(A)</bold>, reporting the Hes-1 positive pixel per field in control (Ctrl) conditions and upon GSP treatment (GSP) in WT and in TAG/F3 mice. Asterisks indicate statistically significant differences: <sup>*</sup><italic>p</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001, through a two-way ANOVA test.</p>
</caption>
<graphic xlink:href="fcell-07-00119-g012"></graphic>
</fig>
</sec>
</sec>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>In this study the mechanisms underlying neuronal developmental parameters and their modulation by adhesion molecule expression and by polyphenol administration are explored through the use of both <italic>in vitro</italic> and <italic>in vivo</italic> approaches. As for the former, in the SH-SY5Y cell line the consequences are explored of polyphenol treatment on both precursor proliferation and on their neuronal commitment/differentiation. A related aspect concerns the significance in such events of axonal adhesive glycoprotein expression profile, for which an <italic>in vivo</italic> approach was rather devised, which took advantage of using transgenic mice models of adhesive glycoproteins mis- and over-expression, known to result into a developmental delay (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>), which represented a valuable tool for testing protective treatments.</p>
<sec id="S4.SS1">
<title>Regulatory Pathways of Neural Developmental Control</title>
<p>The central outcome of this study concerns the control pathways involved in the role of both adhesive glycoproteins and polyphenols in developing nervous tissue patterning, the Notch pathway representing a relevant link between them (<xref ref-type="bibr" rid="B57">Louvi and Artavanis-Tsakonas, 2006</xref>; <xref ref-type="bibr" rid="B82">Pierfelice et al., 2011</xref>; <xref ref-type="bibr" rid="B117">Wang, 2011</xref>; <xref ref-type="bibr" rid="B21">Dhanesh et al., 2016</xref>). Indeed, neural development implies the coordination among a wide set of processes during both early and late neurogenesis (<xref ref-type="bibr" rid="B49">Ishibashi, 2004</xref>; <xref ref-type="bibr" rid="B5">Barros et al., 2011</xref>; <xref ref-type="bibr" rid="B79">Paridaen and Huttner, 2014</xref>; <xref ref-type="bibr" rid="B40">Hardwick et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Clément et al., 2018</xref>), which depends upon precursor interactions with either the surfaces of flanking cells and/or extracellular matrix components (<xref ref-type="bibr" rid="B99">Schmidt and Rathjen, 2010</xref>; <xref ref-type="bibr" rid="B42">Hirano and Takeichi, 2012</xref>; <xref ref-type="bibr" rid="B29">Frei and Stoeckli, 2014</xref>; <xref ref-type="bibr" rid="B80">Petrovic and Schmucker, 2015</xref>). Such interactions are critical for tissue morphogenesis as they modulate precursor differentiation (<xref ref-type="bibr" rid="B81">Pfeuty, 2015</xref>; <xref ref-type="bibr" rid="B51">Kalcheim, 2018</xref>) through activation of signaling pathways (<xref ref-type="bibr" rid="B53">Kanemoto et al., 2014</xref>), among which a key role is played by the one associated with Notch receptors (<xref ref-type="bibr" rid="B93">Ruijtenberg and van den Heuvel, 2016</xref>). Activation of Notch receptors typically results from their interaction with specific ligands, originally identified in the canonical Delta and Serrate proteins (<xref ref-type="bibr" rid="B110">Stump et al., 2002</xref>; <xref ref-type="bibr" rid="B106">Steinbuck and Winandy, 2018</xref>). In turn, such interactions activate a γ-secretase-dependent proteolytic processing, responsible for generating the Notch intracellular domain (NICD), which, upon nuclear translocation, then activates developmental control pathways (<xref ref-type="bibr" rid="B8">Bergmans and De Strooper, 2010</xref>). As a general rule, proteolytic processing may also be relevant in modulating adhesive glycoproteins activation and biological function as typically postulated in the case of at least two components of cell adhesion molecules families: the L1 glycoprotein (<xref ref-type="bibr" rid="B55">Kiefel et al., 2011</xref>; <xref ref-type="bibr" rid="B54">Kataria et al., 2016</xref>) as well as Cadherin family components (<xref ref-type="bibr" rid="B78">Paradies and Grunwald, 1993</xref>; <xref ref-type="bibr" rid="B76">Murata et al., 2014</xref>; <xref ref-type="bibr" rid="B6">Batchuluun et al., 2017</xref>), supporting the hypothesis that besides the canonical Notch pathway also non-canonical Notch activation by structurally different proteins may be involved in its function (<xref ref-type="bibr" rid="B26">D’Souza et al., 2010</xref>).</p>
<p>Among the non-canonical activators, a subset of the immunoglobulin (Ig) supergene family has to be also mentioned, which includes molecules built by the association of Immunoglobulin type C2 with Fibronectin type III (FNIII) repeats (IgC2/FNIII molecules). Such an association is of structural and functional relevance given the similar overall organization of such domains (<xref ref-type="bibr" rid="B17">Cota et al., 2001</xref>); in addition, a peculiarity of such molecules concerns their mode of membrane association, which implies C-terminal GPI-containing lipid anchors, allowing their high level mobility therein and, in addition, their delivery in soluble form. Such an overall organization is demonstrated for all the six Contactin family components, labeled from Contactin1 to Contactin6, in turn characterized by differential expression profiles and therefore developmental roles (<xref ref-type="bibr" rid="B123">Zuko et al., 2011</xref>).</p>
<p>This study focuses on two components of this subset, Contactin1 (<xref ref-type="bibr" rid="B90">Ranscht, 1988</xref>; <xref ref-type="bibr" rid="B34">Gennarini et al., 1989</xref>; <xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>; <xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>) and Contactin2 (<xref ref-type="bibr" rid="B31">Furley et al., 1990</xref>), which display a high level of structural similarity, resulting in a nearly 50% homology in the aminoacid sequences. However, the genes encoding these two molecules sharply differ from each other in terms of their activation profiles, as <italic>Cntn2</italic> peaks at the time of precursor cell cycle exit and neuronal commitment while <italic>Cntn1</italic> is mostly activated in later developmental stages on growing axonal extensions. These data strongly support the hypothesis that the functional and developmental specificity of such molecules largely depends upon the differential activation profiles of the underlying genes.</p>
</sec>
<sec id="S4.SS2">
<title>Contactins Regulatory Functions</title>
<p>Based on the complexity of the mechanisms which drive their regulated expression it has been proposed that Contactins, originally classified among the cell adhesion molecules, should rather fulfil the more general definition of morphoregulatory molecules (<xref ref-type="bibr" rid="B27">Edelman and Jones, 1997</xref>; <xref ref-type="bibr" rid="B33">Gennarini et al., 2017</xref>) as, rather than cell adhesion <italic>per se</italic>, their role implies transmembrane signaling pathways activation. The Notch pathway is part of this morphoregulatory role mostly during the early development when its activation finely modulates the balance of neuronal precursor proliferation versus differentiation events (<xref ref-type="bibr" rid="B121">Zhang et al., 2018</xref>).</p>
</sec>
<sec id="S4.SS3">
<title>Contactin Role in Developmental Control: Molecular and Cellular Bases</title>
<p>In such a mechanism cell cycle control plays a major role. Indeed, at the cellular level, the Notch pathway primary function mostly concerns S phase modulation through the control of cell cycle entry/exit balance and therefore its primary developmental function is to modulate proliferation of precursor cells by shortening their persistence into the G1 phase, thus promoting S phase entry. These effects imply transcriptional activation of the S phase kinase-associated protein SKP2, a subunit of the ubiquitin-ligase SCF<sup>SKP2</sup> complex whose upregulation enhances proteasome-mediated degradation of the Cyclin Kinase inhibitors (CKIs) p21<sup>Cip1</sup> and p27<sup>Kip1</sup> (<xref ref-type="bibr" rid="B13">Bornstein et al., 2003</xref>; <xref ref-type="bibr" rid="B97">Sarmento et al., 2005</xref>), which in turn promotes precursor cell cycle entry and therefore proliferation. At the same time, precursor migration is also promoted, which contributes to the overall positive effects on neurogenesis (<xref ref-type="bibr" rid="B15">Clément et al., 2018</xref>) by modulating the balance of proliferation versus differentiation events (<xref ref-type="bibr" rid="B49">Ishibashi, 2004</xref>; <xref ref-type="bibr" rid="B77">Nelson et al., 2007</xref>). Given that the Notch pathway is activated by interactions with Contactin1 (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>, <xref ref-type="bibr" rid="B45">2006</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), it may then be inferred that a key developmental function of Contactin proteins and of the associated Notch pathway is to mediate the control of tissue patterning, including precursor cell cycle exit, migration and differentiation (<xref ref-type="bibr" rid="B48">Imayoshi et al., 2013</xref>; <xref ref-type="bibr" rid="B21">Dhanesh et al., 2016</xref>; <xref ref-type="bibr" rid="B121">Zhang et al., 2018</xref>).</p>
</sec>
<sec id="S4.SS4">
<title>Significance of Contactin/Notch Interactions in Modulating the Nutritional Input</title>
<p>The above evidences support the known Contactin1 regulatory role in neural developmental control. However, a further relevant aspect arising from the present study concerns the consequences of Contactin/Notch interactions in modulating the effects of the nutritional input, which may still depend upon the activation of specific signaling pathway. It is well known that the mother’s diet influences fetal and in particular neural development through components of the intestinal microbiota which, in turn, may prevent disease outcome and, in particular, neurological disorders, even including autism (<xref ref-type="bibr" rid="B58">Macpherson et al., 2017</xref>; <xref ref-type="bibr" rid="B28">Ficara et al., 2018</xref>; <xref ref-type="bibr" rid="B92">Roman et al., 2018</xref>). Therefore, a relevant aspect of the present study concerns the role of Notch receptors and of the associated signaling pathway in modulating the effects of the nutritional input (<xref ref-type="bibr" rid="B75">Mori et al., 2017</xref>, <xref ref-type="bibr" rid="B95">2018</xref>). Indeed, polyphenols interactions with Notch receptors are known to counteract their function and therefore γ-secretase activation, which results in positive effects on neurogenesis, thus promoting the differentiated phenotype and preventing neuronal damage (<xref ref-type="bibr" rid="B38">Gu et al., 2015</xref>). Inhibition of Notch pathway through the specific effects of polyphenols on γ-secretase therefore may account for the positive effects of such compounds on neurogenesis, which in turn justifies their protective effects against neurodevelopmental delay and neurodegeneration (<xref ref-type="bibr" rid="B25">Donato et al., 2014</xref>).</p>
<p>On this basis, a relevant outcome of the present study is devoted to understanding the mechanisms whereby polyphenols modulate the Notch pathway at the tissue level, which has been addressed through the use of both <italic>in vitro</italic> and <italic>in vivo</italic> approaches.</p>
</sec>
<sec id="S4.SS5">
<title><italic>In vitro</italic> Approaches</title>
<p>In the SH-SY5Y cell line the effects of polyphenol administration on the cell cycle have been explored (<xref ref-type="bibr" rid="B102">Shin et al., 2013</xref>). Polyphenol-treated SH-SY5Y cells underwent upregulation of the CIP Kip family member p27<sup>Kip1</sup>, known to drive precursor cell cycle exit toward the G0 phase at the G1/S interphase (<xref ref-type="bibr" rid="B47">Iacovelli et al., 2007</xref>). These effects are consistent with those exerted on further cell cycle regulators/markers, as indicated by the decrease of Cyclin E expression and of BrdU incorporation in precursor cells. These effects begun at the third day of SH-SY5Y cells polyphenol treatment, a time lapse necessary for activating expression and setting up of molecules mediating cell cycle control and they justify the observed increase in cell cycle exit, demonstrated through expression of neuronal commitment markers and, morphologically, by increased neurite elongation. As for the underlying mechanisms, besides promoting cell cycle exit, p27<sup>Kip1</sup> may also drive neuronal precursor differentiation through its cyclin kinase inhibitory functions (<xref ref-type="bibr" rid="B112">Tury et al., 2011</xref>, <xref ref-type="bibr" rid="B113">2012</xref>) and, in addition, through its ability to suppress RhoA signaling, based on the property of the latter in modulating the neuronal cytoskeleton, thus promoting neuronal differentiation (<xref ref-type="bibr" rid="B15">Clément et al., 2018</xref>).</p>
</sec>
<sec id="S4.SS6">
<title><italic>In vivo</italic> Approaches</title>
<p>In the present study, further data arose from the use of an <italic>in vivo</italic> model consisting in transgenic lines undergoing developmental delay as a consequence of Contactin1 over-expression (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>, <xref ref-type="bibr" rid="B11">2015</xref>), in which the consequences were studied of dietary polyphenol administration. The effects of GSP used as a dietary polyphenol source were explored in modulating neurogenesis by using as a model TAG/F3 mice, undergoing Contactin1 over-expression and Notch pathway upregulation, in turn resulting into a neurodevelopmental delay (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>, <xref ref-type="bibr" rid="B10">2012</xref>). In this transgenic line specific effects including increased precursor proliferation and reduced neuronal commitment/differentiation in different neural regions, including the cerebellum (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), the cerebral cortex (<xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), the basal ganglia (<xref ref-type="bibr" rid="B71">Massaro et al., 2012</xref>) and the hippocampus (<xref ref-type="bibr" rid="B88">Puzzo et al., 2013</xref>) were observed. Therefore it represented a valuable model of impaired neural development, which could mimic the consequences of neurodegenerative disorders, and in which the effects could be tested of polyphenol treatment. Indeed, in this line the inhibitory Contactin1 effects on neurogenesis were efficiently counteracted by polyphenol treatment (see for instance <xref ref-type="fig" rid="F8">Figures 8</xref>, <xref ref-type="fig" rid="F9">9</xref>) and the involvement in this phenotype of the Notch pathway was demonstrated through the concomitant decrease in Hes-1 expression (<xref ref-type="fig" rid="F12">Figure 12</xref>). These effects persisted throughout development as they could be demonstrated at both P0 and P8. However, they were mostly observed at the end of the first postnatal week, when reduced cerebellar size correlated to Contactin1 overexpression. At both developmental stages, an increase in neuronal commitment resulted from polyphenol treatment, mostly evident in Contactin1-overexpressing mice at postnatal day 8. Therefore, these polyphenol-dependent effects in TAG/F3 mice were consistent with those exerted on the Notch pathway.</p>
</sec>
<sec id="S4.SS7">
<title>Polyphenol Effects on Contactins and Hes-1 Expression</title>
<p>Consistent relevant data arising from the present study concern the polyphenol-dependent decrease of both Contactin1 and Contactin2 expression arising from polyphenol treatment in both genotypes and in both considered developmental stages (P0 and P8). Since Contactin1 is an alternative ligand of Notch (<xref ref-type="bibr" rid="B44">Hu et al., 2003</xref>, <xref ref-type="bibr" rid="B45">2006</xref>; <xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), a decrease in its expression could account for the observed decrease in Notch activation, deduced from the concomitant decrease in Hes-1 expression. However, such polyphenol effects do not seem to be specific for Contactin1 as a Contactin2 decrease was observed at the same time in TAG/F3 mice. The inhibitory polyphenol effect on adhesion molecules expression is known in the literature, and it arises from studies concerning the relationships between redox cell state and adhesion molecules expression (<xref ref-type="bibr" rid="B14">Carluccio et al., 2003</xref>). It is worth mentioning that the observed effects on Contactins expression were consistent with those observed on the cerebellar size, also reduced at P8 (see <xref ref-type="fig" rid="F7">Figure 7</xref>), thus supporting the hypothesis that the primary effects of polyphenol treatment was on the adhesion protein expression itself and on the subsequent precursor commitment toward the neuronal phenotype.</p>
<p>Based on the above findings, it may then be interesting to interpret the polyphenol effects on neuronal precursors changes observed on the cerebellar neurons in relation to those on the Notch pathway. In the TAG/F3 model, previous studies demonstrated that Contactin1 overexpression correlates with a Notch pathway activation, with a concomitant decreased expression of cell cycle exit (p27<sup>Kip1</sup>) and neuronal commitment and increased expression of proliferation (BrdU) markers (<xref ref-type="bibr" rid="B10">Bizzoca et al., 2012</xref>), thus justifying positive Contactin1 effects on precursor proliferation and negative effects on cell cycle exit and neuronal commitment, which resulted into a developmental delay.</p>
<p>In the present study, the effects of polyphenol administration were similarly explored on Contactins adhesion molecules expression itself, which was clearly reduced as a consequence of polyphenol treatment. Given the positive Contactin1 effects on the Notch pathway, this resulted in opposite effects on neuronal commitment, so that, in the presence of polyphenols, cell cycle exit was clearly promoted as demonstrated by the increase in both p27<sup><italic>kip</italic></sup> and NeuN expression (<xref ref-type="fig" rid="F8">Figures 8</xref>, <xref ref-type="fig" rid="F9">9</xref>).</p>
<p>These effects could be deduced by the use of both <italic>in vitro</italic> and <italic>in vivo</italic> approaches. In the former, using the SH-SY5Y cells demonstrated positive effects of polyphenol administration on the differentiated phenotype, indicated by increased cell cycle exit and neuronal commitment markers. <italic>In vivo</italic>, in the previously generated model of neural developmental delay represented by the TAG/F3 mice (<xref ref-type="bibr" rid="B12">Bizzoca et al., 2003</xref>), phenotype analysis revealed an overall positive effect of polyphenol administration, essentially at postnatal day 8, when the significant decrease in cerebellar neurogenesis demonstrated in TAG/F3 mice, dependent upon Notch pathway activation by Contactin1, was efficiently counteracted upon polyphenol administration.</p>
<p>The link between Contactins expression, Notch pathway activation and Cip/Kip family factors expression is consistent with the literature data (<xref ref-type="bibr" rid="B97">Sarmento et al., 2005</xref>), indicating a reverse relationship between the Notch pathway activation and p27<sup>Kip1</sup> factor expression, which correlates with the inhibitory effects of polyphenols on γ-secretase activity (<xref ref-type="bibr" rid="B38">Gu et al., 2015</xref>). It could then be supposed that such a relationship may definitely account for the positive effects of polyphenols on neurogenesis so that treatment with such compounds may efficiently counteract neuronal damage.</p>
<p>Besides the demonstrated effects of Notch pathway activation, future studies will be necessary to investigate whether in the chosen model system polyphenols may exert their function also through the expression of neurogenic factors as BDNF, which contributes to neurogenesis, synaptic growth, and neuron survival (<xref ref-type="bibr" rid="B114">Valente et al., 2009</xref>). In this context, the peripheral cytokine network aimed at deciphering the immune homeostasis could be also taken into account based on the possibility that peripheral mediators even including release of nitric oxide (<xref ref-type="bibr" rid="B66">Magrone et al., 2007</xref>) are transported to the CNS, thus exerting <italic>in situ</italic> their influence also on the Contactin/Notch pathway.</p>
</sec>
</sec>
<sec id="S5">
<title>Ethics Statement</title>
<p>Animals were bred in “Department of Basic Medical Sciences, Neurosciences and Sensory Organs,” University of Bari Aldo Moro, Italy and experimentation conformed the EU directive 2010/63/EU by following the Italian Ministry of Health (law of March 4, 2014, n. 26) upon the Authorization n.982/2016.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>SP was involved in setting up the animal models used in the present study on which the whole <italic>in vivo</italic> experimental work was done. AB performed the phenotype analysis of such <italic>in vivo</italic> models. PC analyzed the results obtained on cell lines. TM did comparison of the effects observed in the nervous tissue with those potentially expected in the immune system. EJ and GG coordinated the studies performed in parallel on the nervous and the immune systems.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was supported by grants from the Italian Ministry of Education and Research (Proalifun project PON02 00186 2937475) as well as institutional grants from the University of Bari Aldo Moro.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abolhassani</surname><given-names>N.</given-names></name><name><surname>Leon</surname><given-names>J.</given-names></name><name><surname>Sheng</surname><given-names>Z.</given-names></name><name><surname>Oka</surname><given-names>S.</given-names></name><name><surname>Hamasaki</surname><given-names>H.</given-names></name><name><surname>Iwaki</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer’s disease brain.</article-title>
<source/><italic>Mech. Ageing Dev.</italic>
<volume>161</volume>
<fpage>95</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2016.05.005</pub-id>
<pub-id pub-id-type="pmid">27233446</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera</surname><given-names>G.</given-names></name><name><surname>Colín-González</surname><given-names>A. L.</given-names></name><name><surname>Rangel-López</surname><given-names>E.</given-names></name><name><surname>Chavarría</surname><given-names>A.</given-names></name><name><surname>Santamaría</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Redox signaling, neuroinflammation, and neurodegeneration.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>28</volume>
<fpage>1626</fpage>–<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2017.7099.Abo</pub-id>
<pub-id pub-id-type="pmid">28467722</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>T.</given-names></name><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Tariq</surname><given-names>A.</given-names></name><name><surname>Šamec</surname><given-names>D.</given-names></name><name><surname>Tejada</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Resveratrol and Alzheimer’s disease: mechanistic insights.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>2622</fpage>–<lpage>2635</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9839-9</pub-id>
<pub-id pub-id-type="pmid">26993301</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Alves</surname><given-names>M. G.</given-names></name><name><surname>Sousa</surname><given-names>M.</given-names></name><name><surname>Oliveira</surname><given-names>P. F.</given-names></name><name><surname>Silva</surname><given-names>B. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Are Polyphenols strong dietary agents against neurotoxicity and neurodegeneration?</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>30</volume>
<fpage>345</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-015-9590-4</pub-id>
<pub-id pub-id-type="pmid">26745969</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>C. S.</given-names></name><name><surname>Franco</surname><given-names>S. J.</given-names></name><name><surname>Muller</surname><given-names>U.</given-names></name></person-group> (<year>2011</year>). <article-title>Extracellular matrix: functions in the nervous system.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>3</volume>:<issue>a005108</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a005108</pub-id>
<pub-id pub-id-type="pmid">21123393</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batchuluun</surname><given-names>K.</given-names></name><name><surname>Azuma</surname><given-names>M.</given-names></name><name><surname>Yashiro</surname><given-names>T.</given-names></name><name><surname>Kikuchi</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Notch signaling-mediated cell-to-cell interaction is dependent on E-cadherin adhesion in adult rat anterior pituitary.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>368</volume>
<fpage>125</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-016-2540-5</pub-id>
<pub-id pub-id-type="pmid">27942853</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bensalem</surname><given-names>J.</given-names></name><name><surname>Dudonné</surname><given-names>S.</given-names></name><name><surname>Gaudout</surname><given-names>D.</given-names></name><name><surname>Servant</surname><given-names>L.</given-names></name><name><surname>Calon</surname><given-names>F.</given-names></name><name><surname>Desjardins</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Polyphenol-rich extract from grape and blueberry attenuates cognitive decline and improves neuronal function in aged mice.</article-title>
<source/><italic>J. Nutr. Sci.</italic>
<volume>7</volume>:<issue>e19</issue>. <pub-id pub-id-type="doi">10.1017/jns.2018.10</pub-id>
<pub-id pub-id-type="pmid">29854398</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmans</surname><given-names>B. A.</given-names></name><name><surname>De Strooper</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>gamma-secretases: from cell biology to therapeutic strategies.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>9</volume>
<fpage>215</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(09)70332-1</pub-id>
<pub-id pub-id-type="pmid">20129170</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>The mouse F3/Contactin glycoprotein: structural features, functional properties and developmental significance of its regulated expression.</article-title>
<source/><italic>Cell Adhes. Migrat.</italic>
<volume>3</volume>
<fpage>53</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.4161/cam.3.1.7462</pub-id>
<pub-id pub-id-type="pmid">19372728</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Polizzi</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>M. F.</given-names></name><name><surname>Xenaki</surname><given-names>D.</given-names></name><name><surname>Furley</surname><given-names>A. J. W.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>F3/Contactin acts as a modulator of neurogenesis during cerebral cortex development.</article-title>
<source/><italic>Dev. Biol.</italic>
<volume>365</volume>
<fpage>133</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.02.011</pub-id>
<pub-id pub-id-type="pmid">22360968</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Picocci</surname><given-names>S.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Arbia</surname><given-names>S.</given-names></name><name><surname>Croci</surname><given-names>L.</given-names></name><name><surname>Consalez</surname><given-names>G. G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The gene encoding the mouse contactin-1 axonal glycoprotein is regulated by the collier/Olf1/EBF family early B-Cell factor 2 transcription factor.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>75</volume>
<fpage>1420</fpage>–<lpage>1440</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22293</pub-id>
<pub-id pub-id-type="pmid">25820347</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Virgintino</surname><given-names>D.</given-names></name><name><surname>Lorusso</surname><given-names>L.</given-names></name><name><surname>Buttiglione</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>L.</given-names></name><name><surname>Polizzi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Transgenic mice expressing F3/Contactin from the TAG-1 promoter exhibit developmentally regulated changes in the differentiation of cerebellar neurons.</article-title>
<source/><italic>Development</italic>
<volume>130</volume>
<fpage>29</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00183</pub-id>
<pub-id pub-id-type="pmid">12441289</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornstein</surname><given-names>G.</given-names></name><name><surname>Bloom</surname><given-names>J.</given-names></name><name><surname>Sitry-Shevah</surname><given-names>D.</given-names></name><name><surname>Nakayama</surname><given-names>K.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name><name><surname>Hershko</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>25752</fpage>–<lpage>25757</lpage>. <pub-id pub-id-type="pmid">12730199</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carluccio</surname><given-names>M. A.</given-names></name><name><surname>Siculella</surname><given-names>L.</given-names></name><name><surname>Ancora</surname><given-names>M. A.</given-names></name><name><surname>Massaro</surname><given-names>M.</given-names></name><name><surname>Scoditti</surname><given-names>E.</given-names></name><name><surname>Stornelli</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals.</article-title>
<source/><italic>Arterioscler. Thromb. Vasc. Biol.</italic>
<volume>23</volume>
<fpage>622</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1161/01.atv.0000062884.69432.a0</pub-id>
<pub-id pub-id-type="pmid">12615669</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clément</surname><given-names>O.</given-names></name><name><surname>Hemming</surname><given-names>I. A.</given-names></name><name><surname>Gladwyn-Ng</surname><given-names>I. E.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>S. S.</given-names></name><name><surname>Piper</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Rp58 and p27kip1 coordinate cell cycle exit and neuronal migration within the embryonic mouse cerebral cortex.</article-title>
<source/><italic>Neural Dev.</italic>
<volume>13</volume>:<issue>1</issue>. <pub-id pub-id-type="doi">10.1186/s13064-017-0098-x</pub-id>
<pub-id pub-id-type="pmid">29325591</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coluccia</surname><given-names>A.</given-names></name><name><surname>Tattoli</surname><given-names>M.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Arbia</surname><given-names>S.</given-names></name><name><surname>Lorusso</surname><given-names>L.</given-names></name><name><surname>De Benedictis</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Transgenic mice expressing F3/Contactin from the transient axonal glycoprotein promoter undergo developmentally regulated deficits of the cerebellar function.</article-title>
<source/><italic>Neuroscience</italic>
<volume>123</volume>
<fpage>155</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.08.025</pub-id>
<pub-id pub-id-type="pmid">14667450</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cota</surname><given-names>E.</given-names></name><name><surname>Steward</surname><given-names>A.</given-names></name><name><surname>Fowler</surname><given-names>S. B.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>The folding nucleus of a fibronectin type III domain is composed of core residues of the immunoglobulin-like fold.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>305</volume>
<fpage>1185</fpage>–<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2000.4378</pub-id>
<pub-id pub-id-type="pmid">11162123</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuevas</surname><given-names>C.</given-names></name><name><surname>Huenchuguala</surname><given-names>S.</given-names></name><name><surname>Muñoz</surname><given-names>P.</given-names></name><name><surname>Villa</surname><given-names>M.</given-names></name><name><surname>Paris</surname><given-names>I.</given-names></name><name><surname>Mannervik</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>27</volume>
<fpage>217</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-014-9500-1</pub-id>
<pub-id pub-id-type="pmid">25403520</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Benedictis</surname><given-names>L.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Alberi</surname><given-names>I.</given-names></name><name><surname>Consalez</surname><given-names>G. G.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Activation profile of the F3/Contactin gene in the developing mouse cerebellum.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>32</volume>
<fpage>403</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2006.06.007</pub-id>
<pub-id pub-id-type="pmid">16857383</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Mi</surname><given-names>M. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Resveratrol attenuates Aβ25-35 caused neurotoxicity by inducing autophagy through the TyrRS-PARP1-SIRT1 signaling pathway.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>41</volume>
<fpage>2367</fpage>–<lpage>2379</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-1950-9</pub-id>
<pub-id pub-id-type="pmid">27180189</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanesh</surname><given-names>S. B.</given-names></name><name><surname>Subashini</surname><given-names>C.</given-names></name><name><surname>James</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Hes1: the maestro in neurogenesis.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>73</volume>
<fpage>4019</fpage>–<lpage>4042</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-016-2277-z</pub-id>
<pub-id pub-id-type="pmid">27233500</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>M. L.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Man</surname><given-names>Y. G.</given-names></name><name><surname>Lv</surname><given-names>H. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR signalling pathways in neonatal mice.</article-title>
<source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>95</volume>
<fpage>1396</fpage>–<lpage>1405</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2016-0333</pub-id>
<pub-id pub-id-type="pmid">28679060</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dityatev</surname><given-names>A.</given-names></name><name><surname>Bukalo</surname><given-names>O.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules.</article-title>
<source/><italic>Neuron Glia Biol.</italic>
<volume>4</volume>
<fpage>197</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925X09990111</pub-id>
<pub-id pub-id-type="pmid">19674506</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>J.</given-names></name><name><surname>Morton</surname><given-names>S. B.</given-names></name><name><surname>Karagogeos</surname><given-names>D.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Jessell</surname><given-names>T. M.</given-names></name></person-group> (<year>1988</year>). <article-title>Spatial regulation of axonal glycoprotein expression on subsets of embryonic spinal neurons.</article-title>
<source/><italic>Neuron</italic>
<volume>1</volume>
<fpage>105</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(88)90194-8</pub-id>
<pub-id pub-id-type="pmid">3272160</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>F.</given-names></name><name><surname>de Gomes</surname><given-names>M. G.</given-names></name><name><surname>Goes</surname><given-names>A. T.</given-names></name><name><surname>Filho</surname><given-names>C. B.</given-names></name><name><surname>Del Fabbro</surname><given-names>L.</given-names></name><name><surname>Antunes</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Hesperidin exerts antidepressant-like effects in acute and chronic treatment in mice: possible role of L-arginine-NO-cGMP pathway and BDNF levels.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>104</volume>
<fpage>19</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2014.03.004</pub-id>
<pub-id pub-id-type="pmid">24709058</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Souza</surname><given-names>B.</given-names></name><name><surname>Meloty-Kapella</surname><given-names>L.</given-names></name><name><surname>Weinmaster</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Canonical and non-canonical Notch ligands.</article-title>
<source/><italic>Curr. Top. Dev. Biol.</italic>
<volume>92</volume>
<fpage>73</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/S0070-2153(10)92003-6</pub-id>
<pub-id pub-id-type="pmid">20816393</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelman</surname><given-names>G. M.</given-names></name><name><surname>Jones</surname><given-names>F. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Gene regulation of cell adhesion molecules in neural morphogenesis.</article-title>
<source/><italic>Acta Pediatr. Suppl.</italic>
<volume>422</volume>
<fpage>12</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.1997.tb18338.x</pub-id>
<pub-id pub-id-type="pmid">9298786</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ficara</surname><given-names>M.</given-names></name><name><surname>Pietrella</surname><given-names>E.</given-names></name><name><surname>Spada</surname><given-names>C.</given-names></name><name><surname>Della Casa Muttini</surname><given-names>E.</given-names></name><name><surname>Lucaccioni</surname><given-names>L.</given-names></name><name><surname>Iughetti</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Changes of intestinal microbiota in early life.</article-title>
<source/><italic>J. Matern. Fetal Neonatal Med.</italic>
<volume>10</volume>
<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1080/14767058.2018.1506760</pub-id>
<pub-id pub-id-type="pmid">30058404</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>J. A.</given-names></name><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name></person-group> (<year>2014</year>). <article-title>SynCAMs extend their functions beyond the synapse.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>39</volume>
<fpage>1752</fpage>–<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12544</pub-id>
<pub-id pub-id-type="pmid">24628990</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>J. A.</given-names></name><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name></person-group> (<year>2017</year>). <article-title>SynCAMs - From axon guidance to neurodevelopmental disorders.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>81</volume>
<fpage>41</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.08.012</pub-id>
<pub-id pub-id-type="pmid">27594578</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furley</surname><given-names>A. J.</given-names></name><name><surname>Morton</surname><given-names>S. B.</given-names></name><name><surname>Manalo</surname><given-names>D.</given-names></name><name><surname>Karagogeos</surname><given-names>D.</given-names></name><name><surname>Dodd</surname><given-names>J.</given-names></name><name><surname>Jessell</surname><given-names>T. M.</given-names></name></person-group> (<year>1990</year>). <article-title>The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity.</article-title>
<source/><italic>Cell</italic>
<volume>61</volume>
<fpage>157</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(90)90223-2</pub-id>
<pub-id pub-id-type="pmid">2317872</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>You</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Chang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer’s disease via SIRT1/NF-κB pathway.</article-title>
<source/><italic>Metab. Brain Dis.</italic>
<volume>31</volume>
<fpage>771</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-016-9813-2</pub-id>
<pub-id pub-id-type="pmid">26909502</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Picocci</surname><given-names>S.</given-names></name><name><surname>Puzzo</surname><given-names>D.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Furley</surname><given-names>A. J. W.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>81</volume>
<fpage>49</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.11.006</pub-id>
<pub-id pub-id-type="pmid">27871938</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Cibelli</surname><given-names>G.</given-names></name><name><surname>Rougon</surname><given-names>G.</given-names></name><name><surname>Mattei</surname><given-names>M. G.</given-names></name><name><surname>Goridis</surname><given-names>C.</given-names></name></person-group> (<year>1989</year>). <article-title>The mouse neuronal cell surface F3: a phosphatidylinositol-anchored member of the immunoglobulin superfamily related to chicken contactin.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>109</volume>
<fpage>775</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.109.2.775</pub-id>
<pub-id pub-id-type="pmid">2474555</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Durbec</surname><given-names>P.</given-names></name><name><surname>Boned</surname><given-names>A.</given-names></name><name><surname>Rougon</surname><given-names>G.</given-names></name><name><surname>Goridis</surname><given-names>C.</given-names></name></person-group> (<year>1991</year>). <article-title>Transfected F3/F11 neuronal cell surface protein mediates intercellular adhesion and promotes neurite outgrowth.</article-title>
<source/><italic>Neuron</italic>
<volume>6</volume>
<fpage>595</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(91)90062-5</pub-id>
<pub-id pub-id-type="pmid">2015094</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Furley</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cell adhesion molecules in neural development and disease.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>81</volume>
<fpage>1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2017.03.010</pub-id>
<pub-id pub-id-type="pmid">28385508</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>G.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Faustman</surname><given-names>E. M.</given-names></name><name><surname>Costa</surname><given-names>L. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Measurements of cell death in neuronal and glial cells.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>758</volume>
<fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-170-3_11</pub-id>
<pub-id pub-id-type="pmid">21815065</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>L. T.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>S. Z.</given-names></name><name><surname>Liu</surname><given-names>W. W.</given-names></name><name><surname>Shi</surname><given-names>Z. G.</given-names></name><name><surname>Wang</surname><given-names>Q. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Green tea polyphenols protects cochlear hair cells from ototoxicity by inhibiting Notch signalling.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>40</volume>
<fpage>1211</fpage>–<lpage>1219</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-015-1584-3</pub-id>
<pub-id pub-id-type="pmid">25896296</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulisano</surname><given-names>W.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Palmeri</surname><given-names>A.</given-names></name><name><surname>Puzzo</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of the adhesion molecule F3/Contactin in synaptic plasticity and memory.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>81</volume>
<fpage>64</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.12.003</pub-id>
<pub-id pub-id-type="pmid">28038945</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardwick</surname><given-names>L. J.</given-names></name><name><surname>Ali</surname><given-names>F. R.</given-names></name><name><surname>Azzarelli</surname><given-names>R.</given-names></name><name><surname>Philpott</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Cell cycle regulation of proliferation versus differentiation in the central nervous system.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>359</volume>
<fpage>187</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-014-1895-8</pub-id>
<pub-id pub-id-type="pmid">24859217</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>D.</given-names></name><name><surname>Mi</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Epigallocatechin-3-gallate attenuates cerebral cortex damage and promotes brain regeneration in acrylamide-treated rats.</article-title>
<source/><italic>Food Funct.</italic>
<volume>8</volume>
<fpage>2275</fpage>–<lpage>2282</lpage>. <pub-id pub-id-type="doi">10.1039/c6fo01823h</pub-id>
<pub-id pub-id-type="pmid">28561817</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>S.</given-names></name><name><surname>Takeichi</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Cadherins in brain morphogenesis and wiring.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>92</volume>
<fpage>597</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00014.2011</pub-id>
<pub-id pub-id-type="pmid">22535893</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hnit</surname><given-names>S. S.</given-names></name><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Yao</surname><given-names>M.</given-names></name><name><surname>Holst</surname><given-names>J.</given-names></name><name><surname>Bensoussan</surname><given-names>A.</given-names></name><name><surname>De Souza</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>p27kip1 signaling: Trascriptional and post-translational regulation.</article-title>
<source/><italic>Int. J. Biochem. Cell Biol.</italic>
<volume>68</volume>
<fpage>9</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2015.08.005</pub-id>
<pub-id pub-id-type="pmid">26279144</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q. D.</given-names></name><name><surname>Ang</surname><given-names>B. T.</given-names></name><name><surname>Karsak</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>W. P.</given-names></name><name><surname>Cui</surname><given-names>X. Y.</given-names></name><name><surname>Duka</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>F3/Contactin acts as a functional ligand for Notch during oligodendrocyte maturation.</article-title>
<source/><italic>Cell</italic>
<volume>115</volume>
<fpage>163</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(03)00810-9</pub-id>
<pub-id pub-id-type="pmid">14567914</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q. D.</given-names></name><name><surname>Ma</surname><given-names>Q. H.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Xiao</surname><given-names>Z. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Cross-talk between F3/contactin and Notch at axoglial interface: a role in oligodendrocyte development.</article-title>
<source/><italic>Dev. Neurosci.</italic>
<volume>28</volume>
<fpage>25</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1159/000090750</pub-id>
<pub-id pub-id-type="pmid">16508301</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunot</surname><given-names>S.</given-names></name><name><surname>Hirsch</surname><given-names>E. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroinflammatory processes in Parkinson’s disease.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>53(Suppl. 3)</volume>, <fpage>S49</fpage>–<lpage>S58</lpage>. <pub-id pub-id-type="pmid">12666098</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iacovelli</surname><given-names>J.</given-names></name><name><surname>Lopera</surname><given-names>J.</given-names></name><name><surname>Bott</surname><given-names>M.</given-names></name><name><surname>Baldwin</surname><given-names>E.</given-names></name><name><surname>Khaled</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression.</article-title>
<source/><italic>Glia.</italic>
<volume>55</volume>
<fpage>1638</fpage>–<lpage>1647</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20578</pub-id>
<pub-id pub-id-type="pmid">17849471</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imayoshi</surname><given-names>I.</given-names></name><name><surname>Shimojo</surname><given-names>H.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Ohtsuka</surname><given-names>T.</given-names></name><name><surname>Kageyama</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Genetic visualization of Notch signaling in mammalian neurogenesis.</article-title>
<source/><italic>Cell Mol. Life Sci.</italic>
<volume>70</volume>
<fpage>2045</fpage>–<lpage>2057</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-012-1151-x</pub-id>
<pub-id pub-id-type="pmid">22971775</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular mechanisms for morphogenesis of the central nervous system in mammals.</article-title>
<source/><italic>Anat. Sci. Int.</italic>
<volume>79</volume>
<fpage>226</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1111/j.1447-073x.2004.00085.x</pub-id>
<pub-id pub-id-type="pmid">15633461</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jongbloets</surname><given-names>B. C.</given-names></name><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Semaphorin signalling during development.</article-title>
<source/><italic>Development</italic>
<volume>141</volume>
<fpage>3292</fpage>–<lpage>3297</lpage>. <pub-id pub-id-type="doi">10.1242/dev.105544</pub-id>
<pub-id pub-id-type="pmid">25139851</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalcheim</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Neural crest emigration: from start to stop.</article-title>
<source/><italic>Genesis</italic>
<volume>56</volume>:<issue>e23090</issue>. <pub-id pub-id-type="doi">10.1002/dvg.23090</pub-id>
<pub-id pub-id-type="pmid">29369490</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalfon</surname><given-names>L.</given-names></name><name><surname>Youdim</surname><given-names>M. B. H.</given-names></name><name><surname>Mandel</surname><given-names>S. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of bad: implications for neuroprotection.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>100</volume>
<fpage>992</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04265.x</pub-id>
<pub-id pub-id-type="pmid">17156130</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanemoto</surname><given-names>S.</given-names></name><name><surname>Griffin</surname><given-names>J.</given-names></name><name><surname>Markham-Coultes</surname><given-names>K.</given-names></name><name><surname>Aubert</surname><given-names>I.</given-names></name><name><surname>Tandon</surname><given-names>A.</given-names></name><name><surname>George-Hyslop</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Proliferation, differentiation and amyloid-β production in neural progenitor cells isolated from TgCRND8 mice.</article-title>
<source/><italic>Neuroscience</italic>
<volume>261</volume>
<fpage>52</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.12.021</pub-id>
<pub-id pub-id-type="pmid">24361736</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataria</surname><given-names>H.</given-names></name><name><surname>Lutz</surname><given-names>D.</given-names></name><name><surname>Chaudhary</surname><given-names>H.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Small molecule agonists of cell adhesion molecule L1 mimic L1 functions in vivo.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>53</volume>
<fpage>4461</fpage>–<lpage>4483</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9352-6</pub-id>
<pub-id pub-id-type="pmid">26253722</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiefel</surname><given-names>H.</given-names></name><name><surname>Pfeifer</surname><given-names>M.</given-names></name><name><surname>Bondong</surname><given-names>S.</given-names></name><name><surname>Hazin</surname><given-names>J.</given-names></name><name><surname>Altevogt</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Linking L1CAM-mediated signaling to NF-κB activation.</article-title>
<source/><italic>Trends Mol. Med.</italic>
<volume>17</volume>
<fpage>178</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2010.11.005</pub-id>
<pub-id pub-id-type="pmid">21195665</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalkovièová</surname><given-names>M.</given-names></name><name><surname>Danielisová</surname><given-names>V.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotection and antioxidants.</article-title>
<source/><italic>Neural Regen. Res.</italic>
<volume>11</volume>
<fpage>865</fpage>–<lpage>874</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.184447</pub-id>
<pub-id pub-id-type="pmid">27482198</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louvi</surname><given-names>A.</given-names></name><name><surname>Artavanis-Tsakonas</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Notch signalling in vertebrate neural development.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>7</volume>
<fpage>93</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1847</pub-id>
<pub-id pub-id-type="pmid">16429119</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname><given-names>A. J.</given-names></name><name><surname>de Agüero</surname><given-names>M. G.</given-names></name><name><surname>Ganal-Vonarburg</surname><given-names>S. C.</given-names></name></person-group> (<year>2017</year>). <article-title>How nutrition and the maternal microbiota shape the neonatal immune system.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>17</volume>
<fpage>508</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2017.58</pub-id>
<pub-id pub-id-type="pmid">28604736</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Candore</surname><given-names>G.</given-names></name><name><surname>Caruso</surname><given-names>C.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name><name><surname>Covelli</surname><given-names>V.</given-names></name></person-group> (<year>2008a</year>). <article-title>Polyphenols from red wine modulate immune responsiveness: biological and clinical significance.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>14</volume>
<fpage>2733</fpage>–<lpage>2748</lpage>. <pub-id pub-id-type="doi">10.2174/138161208786264098</pub-id>
<pub-id pub-id-type="pmid">18991692</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Panaro</surname><given-names>M. A.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name><name><surname>Covelli</surname><given-names>V.</given-names></name></person-group> (<year>2008b</year>). <article-title>Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: potential therapeutical application of polyphenols to diet-related chronic diseases.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>14</volume>
<fpage>2758</fpage>–<lpage>2766</lpage>. <pub-id pub-id-type="doi">10.2174/138161208786264179</pub-id>
<pub-id pub-id-type="pmid">18991694</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). “<article-title>Effects of Polyphenols on Inflammatory-Allergic Conditions: Experimental and Clinical Evidences</article-title>,” in <source/><italic>Polyphenols: Prevention and Treatment of Human Disease</italic>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Watson</surname><given-names>R.</given-names></name><name><surname>Preedy</surname><given-names>V.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>).</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Marzulli</surname><given-names>G.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>18</volume>
<fpage>34</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2174/138161212798919057</pub-id>
<pub-id pub-id-type="pmid">22211682</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Romita</surname><given-names>P.</given-names></name><name><surname>Verni</surname><given-names>P.</given-names></name><name><surname>Salvatore</surname><given-names>R.</given-names></name><name><surname>Spagnoletta</surname><given-names>A.</given-names></name><name><surname>Magrone</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017a</year>). <article-title>In vitro effects of polyphenols on the peripheral immune responses in nickel-sensitized patients.</article-title>
<source/><italic>Endocr. Metab. Immune Disord. Drug Targets</italic>
<volume>17</volume>
<fpage>324</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.2174/1871530317666171003161314</pub-id>
<pub-id pub-id-type="pmid">28982342</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Russo</surname><given-names>M. A.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group> (<year>2017c</year>). <article-title>Cocoa and dark chocolate polyphenols: from biology to clinical applications.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>8</volume>:<issue>677</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00677</pub-id>
<pub-id pub-id-type="pmid">28649251</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Salvatore</surname><given-names>R.</given-names></name><name><surname>Spagnoletta</surname><given-names>A.</given-names></name><name><surname>Magrone</surname><given-names>M.</given-names></name><name><surname>Russo</surname><given-names>M. A.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group> (<year>2017b</year>). <article-title>In vitro effects of nickel on healthy non-allergic peripheral blood mononuclear cells. the role of red grape polyphenols.</article-title>
<source/><italic>Endocr. Metab. Immune Disord. Drug Targets</italic>
<volume>17</volume>
<fpage>166</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.2174/1871530317666170713145350</pub-id>
<pub-id pub-id-type="pmid">28707594</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Tafano</surname><given-names>A.</given-names></name><name><surname>Jirillo</surname><given-names>F.</given-names></name><name><surname>Panaro</surname><given-names>M. A.</given-names></name><name><surname>Cuzzuol</surname><given-names>P.</given-names></name><name><surname>Cuzzuol</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Red wine consumption and prevention of atherosclerosis: an in vitro model using human peripheral blood mononuclear cells.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>13</volume>
<fpage>3718</fpage>–<lpage>3725</lpage>. <pub-id pub-id-type="doi">10.2174/138161207783018581</pub-id>
<pub-id pub-id-type="pmid">18220811</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Youdim</surname><given-names>M. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>37</volume>
<fpage>304</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.04.012</pub-id>
<pub-id pub-id-type="pmid">15223064</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manso</surname><given-names>C.</given-names></name><name><surname>Querol</surname><given-names>L.</given-names></name><name><surname>Mekaouche</surname><given-names>M.</given-names></name><name><surname>Illa</surname><given-names>I.</given-names></name><name><surname>Devaux</surname><given-names>J. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>
<fpage>1700</fpage>–<lpage>1712</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww062</pub-id>
<pub-id pub-id-type="pmid">27017186</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzulli</surname><given-names>G.</given-names></name><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Kawaguchi</surname><given-names>K.</given-names></name><name><surname>Kumazawa</surname><given-names>Y.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Fermented Grape Marc (FGM): immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseases.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>18</volume>
<fpage>43</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.2174/138161212798919011</pub-id>
<pub-id pub-id-type="pmid">22211687</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzulli</surname><given-names>G.</given-names></name><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Vonghia</surname><given-names>L.</given-names></name><name><surname>Kaneko</surname><given-names>M.</given-names></name><name><surname>Takimoto</surname><given-names>H.</given-names></name><name><surname>Kumazawa</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Immunomodulating and anti-allergic effects of Negroamaro and Koshu <italic>Vitis vinifera</italic> fermented grape marc (FGM).</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>20</volume>
<fpage>864</fpage>–<lpage>868</lpage>. <pub-id pub-id-type="doi">10.2174/138161282006140220120640</pub-id>
<pub-id pub-id-type="pmid">23701568</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massaro</surname><given-names>A.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Pinto</surname><given-names>M. F.</given-names></name><name><surname>Carratù</surname><given-names>M. R.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Significance of F3/Contactin gene expression in cerebral cortex and nigrostriatal development.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>50</volume>
<fpage>221</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22579730</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missaire</surname><given-names>M.</given-names></name><name><surname>Hindges</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of cell adhesion molecules in visual circuit formation: from neurite outgrowth to maps and synaptic specificity.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>75</volume>
<fpage>569</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22267</pub-id>
<pub-id pub-id-type="pmid">25649254</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebiany</surname><given-names>A. N.</given-names></name><name><surname>Harroch</surname><given-names>S.</given-names></name><name><surname>Bouyain</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>New insights into the roles of the contactin cell adhesion molecules in neural development.</article-title>
<source/><italic>Adv. Neurobiol.</italic>
<volume>8</volume>
<fpage>165</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-8090-7_8</pub-id>
<pub-id pub-id-type="pmid">25300137</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moosavi</surname><given-names>F.</given-names></name><name><surname>Hosseini</surname><given-names>R.</given-names></name><name><surname>Saso</surname><given-names>L.</given-names></name><name><surname>Firuzi</surname><given-names>O.</given-names></name></person-group> (<year>2015</year>). <article-title>Modulation of neurotrophic signaling pathways by polyphenols.</article-title>
<source/><italic>Drug Des. Devel. Ther.</italic>
<volume>10</volume>
<fpage>23</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S96936</pub-id>
<pub-id pub-id-type="pmid">26730179</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Koyama</surname><given-names>N.</given-names></name><name><surname>Tan</surname><given-names>J.</given-names></name><name><surname>Segawa</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Town</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer’s disease.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>292</volume>
<fpage>11310</fpage>–<lpage>11325</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.762658</pub-id>
<pub-id pub-id-type="pmid">28512130</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>A.</given-names></name><name><surname>Yoshino</surname><given-names>M.</given-names></name><name><surname>Hikosaka</surname><given-names>M.</given-names></name><name><surname>Okuyama</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Sakano</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>An evolutionary-conserved function of mammalian Notch family members as cell adhesion molecules.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e108535</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0108535</pub-id>
<pub-id pub-id-type="pmid">25255288</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>B. R.</given-names></name><name><surname>Hartman</surname><given-names>B. H.</given-names></name><name><surname>Georgi</surname><given-names>S. A.</given-names></name><name><surname>Lan</surname><given-names>M. S.</given-names></name><name><surname>Reh</surname><given-names>T. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells.</article-title>
<source/><italic>Dev. Biol.</italic>
<volume>304</volume>
<fpage>479</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2007.01.001</pub-id>
<pub-id pub-id-type="pmid">17280659</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradies</surname><given-names>N. E.</given-names></name><name><surname>Grunwald</surname><given-names>G. B.</given-names></name></person-group> (<year>1993</year>). <article-title>Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>36</volume>
<fpage>33</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490360105</pub-id>
<pub-id pub-id-type="pmid">8230319</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paridaen</surname><given-names>J. T.</given-names></name><name><surname>Huttner</surname><given-names>W. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurogenesis during development of the vertebrate central nervous system.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>15</volume>
<fpage>351</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1002/embr.201438447</pub-id>
<pub-id pub-id-type="pmid">24639559</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrovic</surname><given-names>M.</given-names></name><name><surname>Schmucker</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Axonal wiring in neural development: target-independent mechanisms help to establish precision and complexity.</article-title>
<source/><italic>Bioessays</italic>
<volume>37</volume>
<fpage>996</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201400222</pub-id>
<pub-id pub-id-type="pmid">26184069</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeuty</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>A computational model for the coordination of neural progenitor self-renewal and differentiation through Hes1 dynamics.</article-title>
<source/><italic>Development</italic>
<volume>142</volume>
<fpage>477</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1242/dev.112649</pub-id>
<pub-id pub-id-type="pmid">25605780</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierfelice</surname><given-names>T.</given-names></name><name><surname>Alberi</surname><given-names>L.</given-names></name><name><surname>Gaiano</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Notch in the vertebrate nervous system: an old dog with new tricks.</article-title>
<source/><italic>Neuron</italic>
<volume>69</volume>
<fpage>840</fpage>–<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.031</pub-id>
<pub-id pub-id-type="pmid">21382546</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollerberg</surname><given-names>E.</given-names></name><name><surname>Thelen</surname><given-names>K.</given-names></name><name><surname>Theiss</surname><given-names>M. O.</given-names></name><name><surname>Hochlehnert</surname><given-names>B. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of cell adhesion molecules for navigating axons: density matters.</article-title>
<source/><italic>Mech. Dev.</italic>
<volume>130</volume>
<fpage>359</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.mod.2012.11.002</pub-id>
<pub-id pub-id-type="pmid">23183391</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polyak</surname><given-names>K.</given-names></name><name><surname>Kato</surname><given-names>J. Y.</given-names></name><name><surname>Solomon</surname><given-names>M. J.</given-names></name><name><surname>Sherr</surname><given-names>C. J.</given-names></name><name><surname>Massaque</surname><given-names>J.</given-names></name><name><surname>Roberts</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.</article-title>
<source/><italic>Gene Dev.</italic>
<volume>8</volume>
<fpage>9</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1101/gad.8.1.9</pub-id>
<pub-id pub-id-type="pmid">8288131</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pool</surname><given-names>M.</given-names></name><name><surname>Thiemann</surname><given-names>J.</given-names></name><name><surname>Bar-Or</surname><given-names>A.</given-names></name><name><surname>Fournier</surname><given-names>A. E.</given-names></name></person-group> (<year>2008</year>). <article-title>NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth.</article-title>
<source/><italic>J. Neurosci. Methods</italic>
<volume>168</volume>
<fpage>134</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2007.08.029</pub-id>
<pub-id pub-id-type="pmid">17936365</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulose</surname><given-names>S. M.</given-names></name><name><surname>Miller</surname><given-names>M. G.</given-names></name><name><surname>Scott</surname><given-names>T.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Nutritional factors affecting adult neurogenesis and cognitive function.</article-title>
<source/><italic>Adv. Nutr.</italic>
<volume>8</volume>
<fpage>804</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.3945/an.117.016261</pub-id>
<pub-id pub-id-type="pmid">29141966</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puzzo</surname><given-names>D.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Loreto</surname><given-names>C.</given-names></name><name><surname>Guida</surname><given-names>C. A.</given-names></name><name><surname>Gulisano</surname><given-names>W.</given-names></name><name><surname>Frasca</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Role of F3/contactin expression profile in synaptic plasticity and memory in aged mice.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>36</volume>
<fpage>1702</fpage>–<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.01.004</pub-id>
<pub-id pub-id-type="pmid">25659859</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puzzo</surname><given-names>D.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Privitera</surname><given-names>L.</given-names></name><name><surname>Furnari</surname><given-names>D.</given-names></name><name><surname>Giunta</surname><given-names>S.</given-names></name><name><surname>Girolamo</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>F3/Contactin promotes hippocampal neurogenesis, synaptic plasticity, and memory in adult mice.</article-title>
<source/><italic>Hippocampus</italic>
<volume>23</volume>
<fpage>1367</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.22186</pub-id>
<pub-id pub-id-type="pmid">23939883</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Querol</surname><given-names>L.</given-names></name><name><surname>Nogales-Gadea</surname><given-names>G.</given-names></name><name><surname>Rojas-Garcia</surname><given-names>R.</given-names></name><name><surname>Martinez-Hernandez</surname><given-names>E.</given-names></name><name><surname>Diaz-Manera</surname><given-names>J.</given-names></name><name><surname>Suárez-Calvet</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Antibodies to Contactin-1 in chronic inflammatory demyelinating polyneuropathy.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>73</volume>
<fpage>370</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23794</pub-id>
<pub-id pub-id-type="pmid">23280477</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranscht</surname><given-names>B.</given-names></name></person-group> (<year>1988</year>). <article-title>Sequence of contactin, a 130-kD glycoprotein concentrated in areas of interneuronal contact, defines a new member of the immunoglobulin supergene family in the nervous system.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>107</volume>
<fpage>1561</fpage>–<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.107.4.1561</pub-id>
<pub-id pub-id-type="pmid">3049624</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renno</surname><given-names>W. M.</given-names></name><name><surname>Benov</surname><given-names>L.</given-names></name><name><surname>Khan</surname><given-names>K. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.</article-title>
<source/><italic>J. Neurosurg. Spine</italic>
<volume>27</volume>
<fpage>593</fpage>–<lpage>613</lpage>. <pub-id pub-id-type="doi">10.3171/2016.10.SPINE16218</pub-id>
<pub-id pub-id-type="pmid">28777065</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname><given-names>P.</given-names></name><name><surname>Rueda-Ruzafa</surname><given-names>L.</given-names></name><name><surname>Cardona</surname><given-names>D.</given-names></name><name><surname>Cortes-Rodríguez</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Gut-brain axis in the executive function of austism spectrum disorder.</article-title>
<source/><italic>Behav. Pharmacol.</italic>
<volume>29</volume>
<fpage>654</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0000000000000428</pub-id>
<pub-id pub-id-type="pmid">30179883</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruijtenberg</surname><given-names>S.</given-names></name><name><surname>van den Heuvel</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>15</volume>
<fpage>196</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2015.1120925</pub-id>
<pub-id pub-id-type="pmid">26825227</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzicka</surname><given-names>J.</given-names></name><name><surname>Urdzikova</surname><given-names>L. M.</given-names></name><name><surname>Svobodova</surname><given-names>B.</given-names></name><name><surname>Amin</surname><given-names>A. G.</given-names></name><name><surname>Karova</surname><given-names>K.</given-names></name><name><surname>Dubisova</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury?</article-title>
<source/><italic>Neural Regen. Res.</italic>
<volume>13</volume>
<fpage>119</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.224379</pub-id>
<pub-id pub-id-type="pmid">29451216</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadhukhan</surname><given-names>P.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Dutta</surname><given-names>S.</given-names></name><name><surname>Mahalanobish</surname><given-names>S.</given-names></name><name><surname>Sil</surname><given-names>P. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Nutraceuticals: an emerging therapeutic approach against the pathogenesis of Alzheimer’s disease.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>129</volume>
<fpage>100</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2017.11.028</pub-id>
<pub-id pub-id-type="pmid">29183770</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>Y.</given-names></name><name><surname>Rehman</surname><given-names>A.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>M.</given-names></name><name><surname>Hong</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Astroglial U87 cells protect neuronal SH-SY5Y cells from indirect effect of radiation by reducing DNA damage and inhibiting fas mediated apoptotic pathway in coculture system.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>40</volume>
<fpage>1644</fpage>–<lpage>1654</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-015-1642-x</pub-id>
<pub-id pub-id-type="pmid">26142731</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarmento</surname><given-names>L. M.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Limon</surname><given-names>A.</given-names></name><name><surname>Gordon</surname><given-names>W.</given-names></name><name><surname>Fernandes</surname><given-names>J.</given-names></name><name><surname>Tavares</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27kip1 degradation.</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>202</volume>
<fpage>157</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20050559</pub-id>
<pub-id pub-id-type="pmid">15998794</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarubbo</surname><given-names>F.</given-names></name><name><surname>Moranta</surname><given-names>D.</given-names></name><name><surname>Pani</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Dietary polyphenols and neurogenesis: molecular interactions and implication for brain ageing and cognition.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>90</volume>
<fpage>456</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.05.011</pub-id>
<pub-id pub-id-type="pmid">29753753</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>H.</given-names></name><name><surname>Rathjen</surname><given-names>F. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Signalling mechanisms regulating axonal branching in vivo.</article-title>
<source/><italic>Bioessays</italic>
<volume>32</volume>
<fpage>977</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201000054</pub-id>
<pub-id pub-id-type="pmid">20827677</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C. A.</given-names></name><name><surname>Rasband</surname><given-names>W. S.</given-names></name><name><surname>Eliceiri</surname><given-names>K. W.</given-names></name></person-group> (<year>2012</year>). <article-title>NIH Image to ImageJ: 25 years of image analysis.</article-title>
<source/><italic>Nat. Methods</italic>
<volume>9</volume>
<fpage>671</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id>
<pub-id pub-id-type="pmid">22930834</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimoda</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Contactins: emerging key roles in the development and function of the nervous system.</article-title>
<source/><italic>Cell Adh. Migr.</italic>
<volume>3</volume>
<fpage>64</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.4161/cam.3.1.7764</pub-id>
<pub-id pub-id-type="pmid">19262165</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>S. Y.</given-names></name><name><surname>Yoon</surname><given-names>H.</given-names></name><name><surname>Ahn</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>D. W.</given-names></name><name><surname>Bae</surname><given-names>D. H.</given-names></name><name><surname>Koh</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Structural properties of polyphenols causing cell cycle arrest at G1 phase in HCT116 human colorectal cancer cell lines.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>14</volume>
<fpage>16970</fpage>–<lpage>16985</lpage>. <pub-id pub-id-type="doi">10.3390/ijms140816970</pub-id>
<pub-id pub-id-type="pmid">23965967</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A. K.</given-names></name><name><surname>Bissoyi</surname><given-names>A.</given-names></name><name><surname>Kashyap</surname><given-names>M. P.</given-names></name><name><surname>Patra</surname><given-names>P. K.</given-names></name><name><surname>Rizvi</surname><given-names>S. I.</given-names></name></person-group> (<year>2017</year>). <article-title>Autophagy activation alleviates amyloid-β-induced oxidative stress, apoptosis and neurotoxicity in human neuroblastoma SH-SY5Y cells.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>32</volume>
<fpage>351</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-017-9746-5</pub-id>
<pub-id pub-id-type="pmid">28484969</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>J. P.</given-names></name></person-group> (<year>2007</year>). <article-title>The interactions of flavonoids within neuronal signalling pathways.</article-title>
<source/><italic>Genes Nutr.</italic>
<volume>2</volume>
<fpage>257</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1007/s12263-007-0056-z</pub-id>
<pub-id pub-id-type="pmid">18850181</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>J. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Flavonoids and brain health: multiple effects underpinned by common mechanisms.</article-title>
<source/><italic>Genes Nutr.</italic>
<volume>4</volume>
<fpage>243</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s12263-009-0136-3</pub-id>
<pub-id pub-id-type="pmid">19685255</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbuck</surname><given-names>M. P.</given-names></name><name><surname>Winandy</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>A Review of Notch processing with new insights into ligand-independent Notch signaling in T-Cells.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>9</volume>:<issue>1230</issue>
<pub-id pub-id-type="doi">10.3389/immu.2018.01230</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Neural circuit formation in the cerebellum is controlled by cell adhesion molecules of the contactin family.</article-title>
<source/><italic>Cell Adhes. Migrat.</italic>
<volume>4</volume>
<fpage>523</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.4161/cam.4.4.12733</pub-id>
<pub-id pub-id-type="pmid">20622526</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Understanding axon guidance: are we nearly there yet?</article-title>
<source/><italic>Development</italic>
<volume>145</volume>:<issue>dev151415</issue>. <pub-id pub-id-type="doi">10.1242/dev.151415</pub-id>
<pub-id pub-id-type="pmid">29759980</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name><name><surname>Kilinc</surname><given-names>D.</given-names></name><name><surname>Kunz</surname><given-names>B.</given-names></name><name><surname>Kunz</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>G. U.</given-names></name><name><surname>Martines</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Analysis of cell-cell contact mediated by Ig superfamily cell adhesion molecules.</article-title>
<source/><italic>Curr. Protoc. Cell Biol.</italic>
<volume>61</volume>
<fpage>9.5.1</fpage>–<lpage>9.5.85</lpage>. <pub-id pub-id-type="doi">10.1002/0471143030.cb0905s61</pub-id>
<pub-id pub-id-type="pmid">24510806</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stump</surname><given-names>G.</given-names></name><name><surname>Durrer</surname><given-names>A.</given-names></name><name><surname>Klein</surname><given-names>A. L.</given-names></name><name><surname>Lutolf</surname><given-names>S.</given-names></name><name><surname>Suter</surname><given-names>U.</given-names></name><name><surname>Taylor</surname><given-names>V.</given-names></name></person-group> (<year>2002</year>). <article-title>Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain.</article-title>
<source/><italic>Mech. Dev.</italic>
<volume>114</volume>
<fpage>153</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/s0925-4773(02)00043-6</pub-id>
<pub-id pub-id-type="pmid">12175503</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syarifah-Noratiqah</surname><given-names>S. B.</given-names></name><name><surname>Naina-Mohamed</surname><given-names>I.</given-names></name><name><surname>Zulfarina</surname><given-names>M. S.</given-names></name><name><surname>Qodriyah</surname><given-names>H. M. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Natural polyphenols in the treatment of Alzheimer’s disease.</article-title>
<source/><italic>Curr. Drug Targets</italic>
<volume>19</volume>
<fpage>927</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.2174/1389450118666170328122527</pub-id>
<pub-id pub-id-type="pmid">28356027</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tury</surname><given-names>A.</given-names></name><name><surname>Mairet-Coello</surname><given-names>G.</given-names></name><name><surname>DiCicco-Bloom</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>21</volume>
<fpage>1840</fpage>–<lpage>1856</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhq254</pub-id>
<pub-id pub-id-type="pmid">21245411</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tury</surname><given-names>A.</given-names></name><name><surname>Mairet-Coello</surname><given-names>G.</given-names></name><name><surname>DiCicco-Bloom</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>The multiple roles of the cyclin dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>72</volume>
<fpage>821</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20999</pub-id>
<pub-id pub-id-type="pmid">22076965</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>T.</given-names></name><name><surname>Hidalgo</surname><given-names>J.</given-names></name><name><surname>Bolea</surname><given-names>I.</given-names></name><name><surname>Ramirez</surname><given-names>B.</given-names></name><name><surname>Anglés</surname><given-names>N.</given-names></name><name><surname>Reguant</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>18</volume>
<fpage>849</fpage>–<lpage>865</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2009-1188</pub-id>
<pub-id pub-id-type="pmid">19661617</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>de Bari</surname><given-names>L.</given-names></name><name><surname>de Rasmo</surname><given-names>D.</given-names></name><name><surname>Signorile</surname><given-names>A.</given-names></name><name><surname>Henrion-Caude</surname><given-names>A.</given-names></name><name><surname>Contestabile</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a down syndrome mouse model.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1862</volume>
<fpage>1093</fpage>–<lpage>1104</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2016.03.003</pub-id>
<pub-id pub-id-type="pmid">26964795</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgintino</surname><given-names>D.</given-names></name><name><surname>Ambrosini</surname><given-names>M.</given-names></name><name><surname>D’Errico</surname><given-names>P.</given-names></name><name><surname>Bertossi</surname><given-names>M.</given-names></name><name><surname>Papadaki</surname><given-names>C.</given-names></name><name><surname>Karagogeos</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Regional distribution and cell type-specific expression of the mouse F3 axonal glycoprotein a developmental study.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>413</volume>
<fpage>357</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-9861(19991025)413:3&lt;357::aid-cne1&gt;3.0.co;2-s</pub-id>
<pub-id pub-id-type="pmid">10502245</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Notch signaling and Notch signaling modifiers.</article-title>
<source/><italic>Int. J. Biochem. Cell Biol.</italic>
<volume>43</volume>
<fpage>1550</fpage>–<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2011.08.005</pub-id>
<pub-id pub-id-type="pmid">21854867</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xenaki</surname><given-names>D.</given-names></name><name><surname>Martin</surname><given-names>I. B.</given-names></name><name><surname>Yoshida</surname><given-names>L.</given-names></name><name><surname>Ohyama</surname><given-names>K.</given-names></name><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Grumet</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>F3/contactin and TAG1 play antagonistic roles in the regulation of sonic hedgehog-induced cerebellar granule neuron progenitor proliferation.</article-title>
<source/><italic>Development</italic>
<volume>138</volume>
<fpage>519</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1242/dev.051912</pub-id>
<pub-id pub-id-type="pmid">21205796</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xicoy</surname><given-names>H.</given-names></name><name><surname>Wieringa</surname><given-names>B.</given-names></name><name><surname>Martens</surname><given-names>G. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The SH-SY5Y cell line in Parkinson’s disease research: a systematic review.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>12</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.1186/s13024-017-0149-0</pub-id>
<pub-id pub-id-type="pmid">28118852</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>H. R.</given-names></name><name><surname>Hu</surname><given-names>L. S.</given-names></name><name><surname>Li</surname><given-names>G. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease.</article-title>
<source/><italic>Chin. Med. J.</italic>
<volume>123</volume>
<fpage>1086</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="pmid">20497720</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Engler</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title>Notch: an interactive player in neurogenesis and disease.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>371</volume>
<fpage>73</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-017-2641-9</pub-id>
<pub-id pub-id-type="pmid">28620760</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>N.</given-names></name><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Luteolin Reduces BACE1 expression through NF-κB and through Estrogen receptor mediated pathways in HEK293 and SH-SY5Y Cells.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>45</volume>
<fpage>659</fpage>–<lpage>671</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-142517</pub-id>
<pub-id pub-id-type="pmid">25589732</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuko</surname><given-names>A.</given-names></name><name><surname>Bouyain</surname><given-names>S.</given-names></name><name><surname>van der Zwaag</surname><given-names>B.</given-names></name><name><surname>Burbach</surname><given-names>J. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Contactins: structural aspects in relation to developmental functions in brain disease.</article-title>
<source/><italic>Adv. Protein Chem. Struct. Biol.</italic>
<volume>84</volume>
<fpage>143</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-386483-3.00001-X</pub-id>
<pub-id pub-id-type="pmid">21846565</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuko</surname><given-names>A.</given-names></name><name><surname>Kleijer</surname><given-names>K. T.</given-names></name><name><surname>Oguro-Ando</surname><given-names>A.</given-names></name><name><surname>Kas</surname><given-names>M. J.</given-names></name><name><surname>van Daalen</surname><given-names>E.</given-names></name><name><surname>van der Zwaag</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Contactins in the neurobiology of autism.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>719</volume>
<fpage>63</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2013.07.016</pub-id>
<pub-id pub-id-type="pmid">23872404</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>